◀ Back to MTOR
MLST8 — MTOR
Pathways - manually collected, often from reviews:
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
4E-BP1/eIF4E complex (EIF4EBP1-EIF4E)
(modification, activates)
Gingras et al., Genes Dev 1999*, Nojima et al., J Biol Chem 2003, Schalm et al., Curr Biol 2003*, Beugnet et al., J Biol Chem 2003*, Brunn et al., Science 1997*, Burnett et al., Proc Natl Acad Sci U S A 1998
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
p70S6K (RPS6KB1)
(modification, activates)
Nojima et al., J Biol Chem 2003, Moser et al., Mol Cell Biol 1997*, Burnett et al., Proc Natl Acad Sci U S A 1998
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC2 complex (MTOR-MLST8-RICTOR-MAPKAP1-PRR5)
→
PKC alpha (PRKCA)
(regulation of protein stability, activates)
Ikenoue et al., EMBO J 2008
Evidence: mutant phenotype
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
mTORC1 complex (MTOR-MLST8-RPTOR)
→
4E-BP1/eIF4E complex (EIF4EBP1-EIF4E)
(modification, activates)
Moumen et al., Development 2007
Evidence: mutant phenotype, assay
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
YY1 (YY1)
(modification, collaborate)
Cunningham et al., Nature 2007
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
PGC1A (PPARGC1A)
(modification, collaborate)
Cunningham et al., Nature 2007
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
mTORC1/PGC1A/YY1 complex (MTOR-MLST8-RPTOR-PPARGC1A-YY1)
(modification, collaborate)
Cunningham et al., Nature 2007
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
YY1 (YY1)
→
mTORC1/PGC1A/YY1 complex (MTOR-MLST8-RPTOR-PPARGC1A-YY1)
(modification, collaborate)
Cunningham et al., Nature 2007
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
PGC1A (PPARGC1A)
→
mTORC1/PGC1A/YY1 complex (MTOR-MLST8-RPTOR-PPARGC1A-YY1)
(modification, collaborate)
Cunningham et al., Nature 2007
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
IRS1 (IRS1)
(modification, activates)
Ozes et al., Proc Natl Acad Sci U S A 2001, Harrington et al., J Cell Biol 2004*, Um et al., Nature 2004*, Tremblay et al., Proc Natl Acad Sci U S A 2007*, Zhang et al., J Biol Chem 2008*
Evidence: mutant phenotype, assay
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
p70S6K (RPS6KB1)
(modification, activates)
Ozes et al., Proc Natl Acad Sci U S A 2001, Harrington et al., J Cell Biol 2004*, Um et al., Nature 2004*, Tremblay et al., Proc Natl Acad Sci U S A 2007*, Zhang et al., J Biol Chem 2008*
Evidence: mutant phenotype, assay
-
NCI Pathway Database CXCR3-mediated signaling events:
mTORC2 complex (MTOR-RICTOR-MLST8-MAPKAP1)
→
AKT1 (AKT1)
(modification, activates)
Bonacchi et al., J Biol Chem 2001, Smit et al., Blood 2003
Evidence: assay
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
mTORC1 complex (MTOR-MLST8-RPTOR)
→
DEPTOR (DEPTOR)
(modification, collaborate)
Takeuchi et al., J Biol Chem 2001, Moumen et al., Development 2007
Evidence: mutant phenotype
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
mTORC1 complex (MTOR-MLST8-RPTOR)
→
PRAS40 (AKT1S1)
(modification, collaborate)
Takeuchi et al., J Biol Chem 2001, Moumen et al., Development 2007
Evidence: mutant phenotype
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
mTORC1 complex (MTOR-MLST8-RPTOR)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, collaborate)
Takeuchi et al., J Biol Chem 2001, Moumen et al., Development 2007
Evidence: mutant phenotype
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
DEPTOR (DEPTOR)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, collaborate)
Takeuchi et al., J Biol Chem 2001, Moumen et al., Development 2007
Evidence: mutant phenotype
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
PRAS40 (AKT1S1)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, collaborate)
Takeuchi et al., J Biol Chem 2001, Moumen et al., Development 2007
Evidence: mutant phenotype
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
→
AKT1-2-active (AKT1/AKT2)
(modification, collaborate)
Takeuchi et al., J Biol Chem 2001, Moumen et al., Development 2007
Evidence: mutant phenotype
-
NCI Pathway Database mTOR signaling pathway:
mTOR/GBL/PRAS40/DEPTOR complex (MTOR-MLST8-DEPTOR-AKT1S1)
→
RAPTOR (RPTOR)
(modification, collaborate)
Fang et al., Science 2001, Toschi et al., Mol Cell Biol 2009
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTOR/GBL/PRAS40/DEPTOR complex (MTOR-MLST8-DEPTOR-AKT1S1)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, collaborate)
Fang et al., Science 2001, Toschi et al., Mol Cell Biol 2009
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTOR/GBL/PRAS40/DEPTOR complex (MTOR-MLST8-DEPTOR-AKT1S1)
→
None
(modification, collaborate)
Fang et al., Science 2001, Toschi et al., Mol Cell Biol 2009
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
RAPTOR (RPTOR)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, collaborate)
Fang et al., Science 2001, Toschi et al., Mol Cell Biol 2009
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
SREBP1 (SREBF1)
(translocation, activates)
Porstmann et al., Cell Metab 2008*
Evidence: mutant phenotype, assay
-
NCI Pathway Database Class I PI3K signaling events mediated by Akt:
mTORC2 complex (MTOR-RICTOR-MLST8-MAPKAP1)
→
AKT1 (AKT1)
(modification, activates)
Sarbassov et al., Science 2005, Frias et al., Curr Biol 2006, Jacinto et al., Cell 2006
Evidence: mutant phenotype, assay, physical interaction, other species
-
NCI Pathway Database mTOR signaling pathway:
DEPTOR (DEPTOR)
→
mTORC2/DEPTOR complex (MTOR-MLST8-MAPKAP1-DEPTOR-RICTOR-PRR5)
(modification, collaborate)
Huang et al., Mol Cell Biol 2008, Peterson et al., Cell 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
DEPTOR (DEPTOR)
→
mTORC2 complex (MTOR-MLST8-RICTOR-MAPKAP1-PRR5)
(modification, collaborate)
Huang et al., Mol Cell Biol 2008, Peterson et al., Cell 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC2/DEPTOR complex (MTOR-MLST8-MAPKAP1-DEPTOR-RICTOR-PRR5)
→
mTORC2 complex (MTOR-MLST8-RICTOR-MAPKAP1-PRR5)
(modification, collaborate)
Huang et al., Mol Cell Biol 2008, Peterson et al., Cell 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC2/DEPTOR complex (MTOR-MLST8-MAPKAP1-DEPTOR-RICTOR-PRR5)
→
TSC1/TSC2 complex (TSC1-TSC2)
(modification, collaborate)
Huang et al., Mol Cell Biol 2008, Peterson et al., Cell 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
RAC1/GTP complex (RAC1)
→
mTORC2 complex (MTOR-MLST8-RICTOR-MAPKAP1-PRR5)
(regulation of actin cytoskeleton organization, collaborate)
Sarbassov et al., Curr Biol 2004, Jacinto et al., Nat Cell Biol 2004
Evidence: mutant phenotype
-
NCI Pathway Database mTOR signaling pathway:
mTORC2 complex (MTOR-MLST8-RICTOR-MAPKAP1-PRR5)
→
Paxillin (PXN)
(regulation of actin cytoskeleton organization, activates)
Sarbassov et al., Curr Biol 2004, Jacinto et al., Nat Cell Biol 2004
Evidence: mutant phenotype
-
NCI Pathway Database mTOR signaling pathway:
mTORC2 complex (MTOR-MLST8-RICTOR-MAPKAP1-PRR5)
→
RHOA/GTP complex (RHOA)
(regulation of actin cytoskeleton organization, activates)
Sarbassov et al., Curr Biol 2004, Jacinto et al., Nat Cell Biol 2004
Evidence: mutant phenotype
-
NCI Pathway Database LKB1 signaling events:
14-3-3 family (YWHAH/YWHAZ/YWHAQ/SFN/YWHAE/YWHAG/YWHAB)
→
mTORC1 complex complex (MTOR-MLST8-RPTOR-AKT1S1)
(modification, collaborate)
Shaw et al., Cancer Cell 2004, Gwinn et al., Mol Cell 2008
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database LKB1 signaling events:
14-3-3 family (YWHAH/YWHAZ/YWHAQ/SFN/YWHAE/YWHAG/YWHAB)
→
mTORC1 complex/14-3-3 family complex (MTOR-MLST8-RPTOR-AKT1S1-YWHAH_YWHAZ_YWHAQ_SFN_YWHAE_YWHAG_YWHAB)
(modification, collaborate)
Shaw et al., Cancer Cell 2004, Gwinn et al., Mol Cell 2008
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database LKB1 signaling events:
mTORC1 complex complex (MTOR-MLST8-RPTOR-AKT1S1)
→
mTORC1 complex/14-3-3 family complex (MTOR-MLST8-RPTOR-AKT1S1-YWHAH_YWHAZ_YWHAQ_SFN_YWHAE_YWHAG_YWHAB)
(modification, collaborate)
Shaw et al., Cancer Cell 2004, Gwinn et al., Mol Cell 2008
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
mTORC1/ULK1-2/ATG13/FIP200 complex (MTOR-MLST8-RPTOR-ULK1_ULK2-ATG13-RB1CC1)
(modification, collaborate)
Hosokawa et al., Mol Biol Cell 2009, Jung et al., Mol Biol Cell 2009, Ganley et al., J Biol Chem 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
ULK1-2/ATG13/FIP200 complex (ULK1_ULK2-ATG13-RB1CC1)
(modification, collaborate)
Hosokawa et al., Mol Biol Cell 2009, Jung et al., Mol Biol Cell 2009, Ganley et al., J Biol Chem 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1/ULK1-2/ATG13/FIP200 complex (MTOR-MLST8-RPTOR-ULK1_ULK2-ATG13-RB1CC1)
→
ULK1-2/ATG13/FIP200 complex (ULK1_ULK2-ATG13-RB1CC1)
(modification, collaborate)
Hosokawa et al., Mol Biol Cell 2009, Jung et al., Mol Biol Cell 2009, Ganley et al., J Biol Chem 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
RagA-B/GTP/RagC-D/GDP complex (RRAGA_RRAGB-RRAGC_RRAGD)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, activates)
Sancak et al., Science 2008, Kim et al., Nat Cell Biol 2008
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
PML (PML)
→
mTORC1/PRAS40/DEPTOR/PML complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR-PML)
(modification, collaborate)
Bernardi et al., Nature 2006
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
PML (PML)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, collaborate)
Bernardi et al., Nature 2006
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1/PRAS40/DEPTOR/PML complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR-PML)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, collaborate)
Bernardi et al., Nature 2006
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
eIF3/p70S6K complex (RPS6KB1)
(modification, activates)
Isotani et al., J Biol Chem 1999*, Saitoh et al., J Biol Chem 2002*, Nojima et al., J Biol Chem 2003, Ferrari et al., Proc Natl Acad Sci U S A 1992*, Holz et al., Cell 2005, Moser et al., Mol Cell Biol 1997*
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
p70S6K (RPS6KB1)
(modification, activates)
Isotani et al., J Biol Chem 1999*, Saitoh et al., J Biol Chem 2002*, Nojima et al., J Biol Chem 2003, Ferrari et al., Proc Natl Acad Sci U S A 1992*, Holz et al., Cell 2005, Moser et al., Mol Cell Biol 1997*
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database CXCR4-mediated signaling events:
mTORC2 complex (MTOR-RICTOR-MLST8-MAPKAP1)
→
AKT1 (AKT1)
(modification, activates)
Sotsios et al., J Immunol 1999, Curnock et al., J Immunol 2003, Chen et al., Mol Biol Cell 2008
Evidence: assay
-
NCI Pathway Database mTOR signaling pathway:
RICTOR (RICTOR)
→
mTORC2/DEPTOR complex (MTOR-MLST8-MAPKAP1-DEPTOR-RICTOR-PRR5)
(modification, collaborate)
Fang et al., Science 2001, Toschi et al., Mol Cell Biol 2009
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
RICTOR (RICTOR)
→
mTOR/GBL/SIN1/PROTOR1/DEPTOR complex (MTOR-MLST8-DEPTOR-MAPKAP1-PRR5)
(modification, collaborate)
Fang et al., Science 2001, Toschi et al., Mol Cell Biol 2009
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC2/DEPTOR complex (MTOR-MLST8-MAPKAP1-DEPTOR-RICTOR-PRR5)
→
mTOR/GBL/SIN1/PROTOR1/DEPTOR complex (MTOR-MLST8-DEPTOR-MAPKAP1-PRR5)
(modification, collaborate)
Fang et al., Science 2001, Toschi et al., Mol Cell Biol 2009
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
None
→
mTOR/GBL/SIN1/PROTOR1/DEPTOR complex (MTOR-MLST8-DEPTOR-MAPKAP1-PRR5)
(modification, activates)
Fang et al., Science 2001, Toschi et al., Mol Cell Biol 2009
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
CDK2/Cyclin E1 complex (CDK2-CCNE1)
(modification, activates)
Mayer et al., Genes Dev 2004
Evidence: mutant phenotype, assay
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
TIFIA (RRN3)
(modification, activates)
Mayer et al., Genes Dev 2004
Evidence: mutant phenotype, assay
-
NCI Pathway Database mTOR signaling pathway:
mTORC2 complex (MTOR-MLST8-RICTOR-MAPKAP1-PRR5)
→
PKC alpha (PRKCA)
(modification, activates)
Sarbassov et al., Curr Biol 2004, Guertin et al., Dev Cell 2006, Ikenoue et al., EMBO J 2008
Evidence: mutant phenotype
-
NCI Pathway Database LKB1 signaling events:
AMPKK1-AMPKK2-active ()
→
mTORC1 complex complex (MTOR-MLST8-RPTOR-AKT1S1)
(modification, activates)
Gwinn et al., Mol Cell 2008
Evidence: mutant phenotype, assay
-
NCI Pathway Database mTOR signaling pathway:
14-3-3 family (YWHAH/YWHAZ/YWHAQ/SFN/YWHAE/YWHAG/YWHAB)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, collaborate)
Gwinn et al., Mol Cell 2008
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
14-3-3 family (YWHAH/YWHAZ/YWHAQ/SFN/YWHAE/YWHAG/YWHAB)
→
mTORC1/PRAS40/DEPTOR/14-3-3 family complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR-YWHAH_YWHAZ_YWHAQ_SFN_YWHAE_YWHAG_YWHAB)
(modification, collaborate)
Gwinn et al., Mol Cell 2008
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
→
mTORC1/PRAS40/DEPTOR/14-3-3 family complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR-YWHAH_YWHAZ_YWHAQ_SFN_YWHAE_YWHAG_YWHAB)
(modification, collaborate)
Gwinn et al., Mol Cell 2008
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
CLIP170 (CLIP1)
(modification, activates)
Choi et al., EMBO Rep 2002*
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, collaborate)
Garami et al., Mol Cell 2003, Inoki et al., Genes Dev 2003, Vander Haar et al., Nat Cell Biol 2007, Sancak et al., Mol Cell 2007, Wang et al., J Biol Chem 2007, Peterson et al., Cell 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
DEPTOR (DEPTOR)
(modification, collaborate)
Garami et al., Mol Cell 2003, Inoki et al., Genes Dev 2003, Vander Haar et al., Nat Cell Biol 2007, Sancak et al., Mol Cell 2007, Wang et al., J Biol Chem 2007, Peterson et al., Cell 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1 complex (MTOR-MLST8-RPTOR)
→
PRAS40 (AKT1S1)
(modification, collaborate)
Garami et al., Mol Cell 2003, Inoki et al., Genes Dev 2003, Vander Haar et al., Nat Cell Biol 2007, Sancak et al., Mol Cell 2007, Wang et al., J Biol Chem 2007, Peterson et al., Cell 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
AKT1 (AKT1)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, activates)
Garami et al., Mol Cell 2003, Inoki et al., Genes Dev 2003, Vander Haar et al., Nat Cell Biol 2007, Sancak et al., Mol Cell 2007, Wang et al., J Biol Chem 2007, Peterson et al., Cell 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
RHEB/GTP complex (RHEB)
→
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
(modification, activates)
Garami et al., Mol Cell 2003, Inoki et al., Genes Dev 2003, Vander Haar et al., Nat Cell Biol 2007, Sancak et al., Mol Cell 2007, Wang et al., J Biol Chem 2007, Peterson et al., Cell 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
→
DEPTOR (DEPTOR)
(modification, collaborate)
Garami et al., Mol Cell 2003, Inoki et al., Genes Dev 2003, Vander Haar et al., Nat Cell Biol 2007, Sancak et al., Mol Cell 2007, Wang et al., J Biol Chem 2007, Peterson et al., Cell 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC1/PRAS40/DEPTOR complex (MTOR-MLST8-AKT1S1-DEPTOR-RPTOR)
→
PRAS40 (AKT1S1)
(modification, collaborate)
Garami et al., Mol Cell 2003, Inoki et al., Genes Dev 2003, Vander Haar et al., Nat Cell Biol 2007, Sancak et al., Mol Cell 2007, Wang et al., J Biol Chem 2007, Peterson et al., Cell 2009
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database ErbB1 downstream signaling:
mTORC2 complex (MTOR-RICTOR-MLST8-MAPKAP1)
→
AKT1 (AKT1)
(modification, activates)
Sarbassov et al., Science 2005, Cao et al., Science signaling 2009
Evidence: genetic interaction
-
NCI Pathway Database mTOR signaling pathway:
mTORC2 complex (MTOR-MLST8-RICTOR-MAPKAP1-PRR5)
→
AKT1 (AKT1)
(modification, activates)
Sarbassov et al., Science 2005, Frias et al., Curr Biol 2006, Jacinto et al., Cell 2006, Yang et al., Genes Dev 2006, Guertin et al., Dev Cell 2006, Pearce et al., Biochem J 2007, Woo et al., J Biol Chem 2007, Huang et al., Mol Cell Biol 2008, Ikenoue et al., EMBO J 2008
Evidence: mutant phenotype, assay, physical interaction
-
Reactome Reaction:
MTOR
→
MLST8
(direct_complex)
Inoki et al., Microbiol Mol Biol Rev 2005*
-
Reactome Reaction:
MTOR
→
MLST8
(reaction)
Inoki et al., Microbiol Mol Biol Rev 2005*
-
WikiPathways Angiopoietin Like Protein 8 Regulatory Pathway:
RHEB
→
Complex of RPTOR-MLST8-MTOR
(activation)
-
WikiPathways Angiopoietin Like Protein 8 Regulatory Pathway:
AKT1/AKT2
→
Complex of MTOR-MAPKAP1-RICTOR-MLST8
(activation)
-
WikiPathways Angiopoietin Like Protein 8 Regulatory Pathway:
RICTOR
→
Complex of MAPKAP1-RICTOR-MTOR-MLST8
(activation)
Chen et al., Dev Cell 2010*
-
WikiPathways Angiopoietin Like Protein 8 Regulatory Pathway:
Complex of RPTOR-MLST8-MTOR
→
EIF4EBP1
(inhibition)
-
WikiPathways Angiopoietin Like Protein 8 Regulatory Pathway:
Complex of RPTOR-MLST8-MTOR
→
RPS6KB2/RPS6KB1
(mim-conversion)
-
WikiPathways Senescence and Autophagy in Cancer:
MLST8
→
MTOR
(activation)
-
WikiPathways Target Of Rapamycin (TOR) Signaling:
Complex of RPTOR-MLST8-MTOR
→
RPS6KB1
(activation)
-
WikiPathways Target Of Rapamycin (TOR) Signaling:
FKBP1A
→
Complex of RPTOR-MLST8-MTOR
(inhibition)
-
WikiPathways Target Of Rapamycin (TOR) Signaling:
Complex of MLST8-MTOR-MAPKAP1-RICTOR
→
RAC1
(activation)
-
WikiPathways Target Of Rapamycin (TOR) Signaling:
PRKAB1
→
Complex of RPTOR-MLST8-MTOR
(inhibition)
-
WikiPathways Target Of Rapamycin (TOR) Signaling:
Complex of MLST8-MTOR-MAPKAP1-RICTOR
→
PRKCA
(activation)
-
WikiPathways Target Of Rapamycin (TOR) Signaling:
Complex of MLST8-MTOR-MAPKAP1-RICTOR
→
AKT1
(activation)
-
WikiPathways Target Of Rapamycin (TOR) Signaling:
Complex of RPTOR-MLST8-MTOR
→
ULK1
(inhibition)
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Bind Interaction:
Complex of MTOR-MLST8-RICTOR
Jacinto et al., Nat Cell Biol 2004
-
IRef Bind Interaction:
Complex of RPTOR-MLST8-MTOR
Jacinto et al., Nat Cell Biol 2004
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
Wang et al., J Biol Chem 2006*
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
Kaizuka et al., J Biol Chem 2010
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
Kawai et al., Virchows Arch 2003*
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
Behrends et al., Nature 2010
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
Kim et al., Mol Cell 2003*
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
McMahon et al., Mol Endocrinol 2005*
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
Peterson et al., Cell 2009
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
Oshiro et al., Genes Cells 2004*
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
Yan et al., Autophagy 2012*
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
Sarbassov et al., J Biol Chem 2005*
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
Ramírez-Rangel et al., Mol Cell Biol 2011*
-
IRef Biogrid Interaction:
MLST8
—
MTOR
(physical association, affinity chromatography technology)
Martin et al., Biochem Biophys Res Commun 2008
-
MIPS CORUM mTOR-RICTOR complex:
mTOR-RICTOR complex complex (MTOR-MLST8-RICTOR)
Sarbassov et al., Curr Biol 2004
-
MIPS CORUM RICTOR-mTOR complex:
RICTOR-mTOR complex complex (MTOR-MLST8)
Sarbassov et al., Science 2005
-
MIPS CORUM RAPTOR-mTOR complex:
RAPTOR-mTOR complex complex (MTOR-MLST8-RPTOR)
Sarbassov et al., Science 2005
-
MIPS CORUM mTORC2 complex (mTOR/FRAP1, LST8, mAVO3/RICTOR):
mTORC2 complex (mTOR/FRAP1, LST8, mAVO3/RICTOR) complex (MTOR-MLST8-RICTOR)
Jacinto et al., Nat Cell Biol 2004
-
MIPS CORUM mTORC1 complex (mTOR/FRAP1, LST8, RAPTOR):
mTORC1 complex (mTOR/FRAP1, LST8, RAPTOR) complex (MTOR-MLST8-RPTOR)
Jacinto et al., Nat Cell Biol 2004
-
MIPS CORUM mTOR-signaling complex (FRAP1/mTOR, GBL, RAPTOR):
mTOR-signaling complex (FRAP1/mTOR, GBL, RAPTOR) complex (MTOR-MLST8-RPTOR)
Kim et al., Mol Cell 2003*
-
MIPS CORUM mTORC2 complex (mTOR/FRAP1, LST8, mAVO3/RICTOR, SIN1):
mTORC2 complex (mTOR/FRAP1, LST8, mAVO3/RICTOR, SIN1) complex (MTOR-MLST8-MAPKAP1-RICTOR)
Yang et al., Genes Dev 2006
-
MIPS CORUM mTOR-RAPTOR complex:
mTOR-RAPTOR complex complex (MTOR-MLST8-RPTOR)
Sarbassov et al., Curr Biol 2004
-
IRef Corum Interaction:
Complex of MLST8-RICTOR-MTOR-MTOR-RICTOR-MLST8
(association, anti bait coimmunoprecipitation)
Sarbassov et al., Curr Biol 2004
-
IRef Corum Interaction:
Complex of 13 proteins
(association, coimmunoprecipitation)
Sarbassov et al., Science 2005
-
IRef Corum Interaction:
Complex of MTOR-MLST8
(association, coimmunoprecipitation)
Sarbassov et al., Science 2005
-
IRef Dip Interaction:
MLST8
—
MTOR
(direct interaction, ion exchange chromatography)
Yang et al., Nature 2013*
-
IRef Dip Interaction:
MLST8
—
MTOR
(direct interaction, molecular sieving)
Yang et al., Nature 2013*
-
IRef Dip Interaction:
MLST8
—
MTOR
(direct interaction, x-ray crystallography)
Yang et al., Nature 2013*
-
IRef Hprd Interaction:
MLST8
—
MTOR
(in vivo)
Kim et al., Mol Cell 2003*, Oshiro et al., Genes Cells 2004*
-
IRef Innatedb Interaction:
MLST8
—
MTOR
(unknown, -)
Frias et al., Curr Biol 2006
-
IRef Innatedb Interaction:
MLST8
—
MTOR
(unknown, -)
Oshiro et al., Genes Cells 2004*
-
IRef Innatedb Interaction:
MLST8
—
MTOR
(unknown, -)
Vander Haar et al., Nat Cell Biol 2007
-
IRef Innatedb Interaction:
MLST8
—
MTOR
(unknown, -)
Thedieck et al., PloS one 2007*
-
IRef Innatedb Interaction:
MLST8
—
MTOR
(unknown, -)
Kim et al., Mol Cell 2003*
-
IRef Intact Interaction:
Complex of 13 proteins
(association, anti bait coimmunoprecipitation)
Zinzalla et al., Cell 2011
-
IRef Intact Interaction:
MLST8
—
MTOR
(physical association, anti tag coimmunoprecipitation)
Loewith et al., Mol Cell 2002*
-
IRef Intact Interaction:
Complex of 27 proteins
(association, anti bait coimmunoprecipitation)
Pearce et al., Biochem J 2007
-
IRef Intact Interaction:
Complex of PRR5-MTOR-YWHAE-YWHAB-HSPA1A-MLST8-RICTOR
(association, tandem affinity purification)
Pearce et al., Biochem J 2007
-
IRef Intact Interaction:
Complex of RPTOR-MAPKAP1-MTOR-MLST8-PRR5-RICTOR
(association, anti bait coimmunoprecipitation)
Pearce et al., Biochem J 2007
-
IRef Intact Interaction:
Complex of 41 proteins
(association, anti bait coimmunoprecipitation)
Pearce et al., Biochem J 2007
-
IRef Intact Interaction:
Complex of RICTOR-PRR5-MTOR-MAPKAP1-MLST8
(association, anti tag coimmunoprecipitation)
Pearce et al., Biochem J 2007
-
IRef Intact Interaction:
Complex of MTOR-MLST8-RICTOR-MAPKAP1-PRR5L
(association, anti tag coimmunoprecipitation)
Pearce et al., Biochem J 2007
-
IRef Intact Interaction:
Complex of KRT85-MLST8-MTOR-MLST8-CCT2-RPTOR
(physical association, anti tag coimmunoprecipitation)
Behrends et al., Nature 2010
Text-mined interactions from Literome
Zhang et al., Ann Surg Oncol 2011 (Colorectal Neoplasms) :
Additionally,
Indo and Nim could
reduce the
mTOR signaling activity after COX-2 silencing in CRC cells
Murata et al., J Biol Chem 2011 (Neuroblastoma...) :
A new cytosolic pathway from a Parkinson disease associated kinase, BRPK/PINK1 :
activation of
AKT via
mTORC2
Baum et al., Am J Physiol Endocrinol Metab 2009 :
Compared with control livers,
insulin stimulated Akt phosphorylation and
mTORC1 signaling, as assessed by increased phosphorylation of the mTORC1 targets eIF4E binding protein ( 4E-BP ) 1 and ribosomal protein S6 kinase (S6K)1, and promoted assembly of the eIF4G x eIF4E complex ... Overall, the results suggest that
glucagon acts in a dominant manner to
repress insulin induced
mTORC1 signaling, which is in contrast to previous studies showing a dominant action of insulin in the control of hepatic gluconeogenesis ... Overall, the results suggest that glucagon acts in a dominant manner to repress
insulin induced
mTORC1 signaling, which is in contrast to previous studies showing a dominant action of insulin in the control of hepatic gluconeogenesis
Le Bacquer et al., J Endocrinol 2013 (Hyperglycemia) :
mTORC1 and
mTORC2 regulate
insulin secretion through Akt in INS-1 cells ...
mTORC1 and mTORC2
regulate insulin secretion through Akt in INS-1 cells
Han et al., Cell Signal 2008 (Tuberous Sclerosis) :
Pam ( Protein associated with Myc ) functions as an E3 ubiquitin ligase and
regulates TSC/mTOR signaling
Acosta-Jaquez et al., Mol Cell Biol 2009 :
These data provide the first evidence that site-specific mTOR phosphorylation regulates mTORC1 function and suggest a model whereby insulin stimulated
mTOR S1261 phosphorylation
promotes mTORC1 autokinase activity, substrate phosphorylation, and cell growth
Wu et al., Proc Natl Acad Sci U S A 2012 :
However, excessive
miR-17-92 expression
enhances mammalian target of rapamycin
(mTOR) signaling and strongly skews the differentiation toward short lived terminal effector cells
Hsu et al., Science 2011 :
The adaptor protein Grb10 was identified as an mTORC1 substrate that mediates the inhibition of phosphoinositide 3-kinase typical of cells lacking
tuberous sclerosis complex 2 (TSC2) , a tumor suppressor and negative
regulator of
mTORC1
Lodeiro et al., PloS one 2009 :
This beta-arrestin scaffolded complex leads to full
activation of
Akt through PDK1 and
mTORC2 , which are not associated to the complex
Agarwal et al., Oncogene 2013 :
We found that a suppression of RhoGDI2 by rictor is not related to the Sin1 or raptor function that excludes a
role of
mTORC2 or mTORC1 in regulation of
RhoGDI2 ... We found that a suppression of RhoGDI2 by rictor is not related to the Sin1 or raptor function that excludes a
role of mTORC2 or
mTORC1 in regulation of
RhoGDI2
Wang et al., Biochem Biophys Res Commun 2012 (Vitreoretinopathy, Proliferative) :
TNF-a promotes human retinal pigment epithelial (RPE) cell migration by
inducing matrix metallopeptidase 9 (MMP-9) expression through activation of
Akt/mTORC1 signaling ... In conclusion, this study suggest that TNF-a promotes RPE cell migration by
inducing MMP-9 expression through activation of Akt/
mTORC1 , but not mTORC2 signaling ... In conclusion, this study suggest that TNF-a promotes RPE cell migration by
inducing MMP-9 expression through activation of Akt/ mTORC1, but not
mTORC2 signaling
Regazzetti et al., PloS one 2012 (MAP Kinase Signaling System) :
In 3T3-L1 adipocytes, silencing of
REDD1 with siRNA
induces an increase of
mTORC1 activity as well as an inhibition of insulin signaling pathway and lipogenesis
Wang et al., Oncogene 2008 (Prostatic Neoplasms) :
Inhibition of both mTORC1 and
mTORC2 by rapamycin induced apoptosis, whereas rapamycin-stimulation of AR transcriptional activity
resulted from the inhibition of mTORC1, but not
mTORC2 ... Inhibition of both
mTORC1 and mTORC2 by rapamycin induced apoptosis, whereas rapamycin-stimulation of AR transcriptional activity
resulted from the inhibition of mTORC1, but not
mTORC2 ... Inhibition of both mTORC1 and
mTORC2 by rapamycin induced apoptosis, whereas rapamycin-stimulation of AR transcriptional activity
resulted from the inhibition of
mTORC1 , but not mTORC2 ... Inhibition of both
mTORC1 and mTORC2 by rapamycin induced apoptosis, whereas rapamycin-stimulation of AR transcriptional activity
resulted from the inhibition of
mTORC1 , but not mTORC2
Prabhu et al., Oncogene 2007 (Leukemia, Myelogenous, Chronic, BCR-ABL Positive) :
In this study, we found that both Bcr-Abl and the rapamycin-sensitive
mTORC1 complex contribute to the phosphorylation ( inactivation ) of
4E-BP1 , an inhibitor of the eIF4E translation initiation factor ... Experiments with rapamycin and the Bcr-Abl inhibitor, imatinib mesylate, in Bcr-Abl expressing cell lines and primary CML cells indicated that Bcr-Abl and
mTORC1 induced formation of the translation initiation complex,
eIF4F
Lian et al., J Biol Chem 2012 :
Furthermore, inhibition of
PI3K/Akt/mTOR signaling , but not canonical Smad signaling, downstream of TGFß,
blocked TGFß induced synthesis of
vimentin , and inhibited ATF4 dependent Ocn transcription in osteoblasts
Kumar et al., Diabetes 2010 :
To determine the physiological
role of
rictor/mTORC2 in
insulin signaling and action in fat cells, we developed fat cell-specific rictor knockout ( FRic ( -/- ) ) mice
Vadysirisack et al., Methods Mol Biol 2012 :
Our work has demonstrated that the stress induced protein REDD1 is essential for hypoxia regulation of mTORC1 activity and has further defined the molecular mechanism whereby
REDD1 represses
mTORC1 activity under hypoxic stress ... Our work has demonstrated that the stress induced protein
REDD1 is
essential for hypoxia regulation of
mTORC1 activity and has further defined the molecular mechanism whereby REDD1 represses mTORC1 activity under hypoxic stress
Lee et al., Carcinogenesis 2010 (Colonic Neoplasms) :
In contrast, the
Akt dependent
mTORC1 inhibition by selenium did not require AMPKalpha ( 1 )
Lamming et al., Science 2012 (Insulin Resistance) :
We demonstrate that rapamycin disrupted a second
mTOR complex, mTORC2, in vivo and that
mTORC2 was
required for the insulin mediated suppression of hepatic gluconeogenesis
Yao et al., Science signaling 2013 :
BSTA promotes
mTORC2 mediated phosphorylation of
Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiation ... The mammalian target of rapamycin complex 2 ( mTORC2 ) facilitated the phosphorylation of BSTA and its association with Akt1, and the
BSTA-Akt1 interaction
promoted the association of
mTORC2 with Akt1 and phosphorylation of Akt1 at Ser473 in response to growth factor stimulation ... The
mammalian target of rapamycin complex 2 ( mTORC2 ) facilitated the phosphorylation of BSTA and its association with Akt1, and the BSTA-Akt1 interaction
promoted the association of
mTORC2 with Akt1 and phosphorylation of Akt1 at Ser473 in response to growth factor stimulation
Haslinger et al., Biol Reprod 2013 :
Accordingly, a decrease in
EGF stimulated phosphorylation of AKT ( Ser473 and Thr308 ) and its downstream target
mTORC1 ( Ser2448 ) was noticed in AKT1 and AKT3 shRNAmir cell pools
Fonseca et al., Biochem J 2008 :
The binding of PRAS40 to 14-3-3 proteins is not required for
activation of
mTORC1 signalling by phorbol
esters/ERK
Ng et al., Cell Death Differ 2012 :
However, AMPK activation represses the mTOR complex-1 (mTORC1) pathway only in transformed cells, suggesting a key role for
AMPK mediated
mTORC1 inhibition in the suppression of anoikis ... Our data implicate
AMPK mediated
mTORC1 inhibition and suppression of protein synthesis as a means for bioenergetic conservation during detachment, thus promoting anoikis resistance
Bridges et al., Mol Biol Cell 2012 :
In this paper, we show that
PIKFYVE and PI3K-C2a are
necessary for activation of
mTORC1 and its translocation to the plasma membrane in 3T3-L1 adipocytes ... In this paper, we show that PIKFYVE and
PI3K-C2a are
necessary for activation of
mTORC1 and its translocation to the plasma membrane in 3T3-L1 adipocytes
Fang et al., Curr Biol 2003 :
PLD1 regulates
mTOR signaling and mediates Cdc42 activation of S6K1 ... Our observations reveal the
involvement of
PLD1 in
mTOR signaling and cell size control, and provide a molecular mechanism for Cdc42 activation of S6K1
Tillu et al., Molecular pain 2012 (Acute Pain...) :
We reasoned that activators of AMP activated protein kinase (AMPK) may represent a novel treatment avenue for the local treatment of incision induced pain because
AMPK activators
inhibit ERK and
mTOR signaling , two important pathways involved in the sensitization of peripheral nociceptors
Melnik , Hautarzt 2013 (Acne Vulgaris...) :
mTORC1 , the central hub of protein- and lipid biosynthesis, cell growth and proliferation, is
activated by insulin,
IGF-1 and branched-chain essential amino acids, especially leucine ...
mTORC1 , the central hub of protein- and lipid biosynthesis, cell growth and proliferation, is
activated by insulin,
IGF-1 and branched-chain essential amino acids, especially leucine ...
mTORC1 , the central hub of protein- and lipid biosynthesis, cell growth and proliferation, is
activated by
insulin , IGF-1 and branched-chain essential amino acids, especially leucine
Kim et al., Mol Cell Biol 2008 :
Subsequent studies established that
GIP increased the nuclear localization of
TORC2 and phosphorylation of CREB serine 133 through a pathway involving PKA activation and reduced AMPK phosphorylation ... The antiapoptotic effect of GIP in beta cells is therefore partially mediated through a novel mode of transcriptional regulation of Bcl-2 involving
cAMP/PKA/AMPK dependent regulation of
CREB/TORC2 activity ... The antiapoptotic effect of GIP in beta cells is therefore partially mediated through a novel mode of transcriptional regulation of Bcl-2 involving
cAMP/PKA/AMPK dependent regulation of
CREB/TORC2 activity
Rao et al., Immunity 2012 :
The Foxo1 inactivation was dependent on mTORC1 kinase, given that blockade of
mTORC1 abrogated
mTORC2 mediated Akt ( Ser473 ) kinase phosphorylation, resulting in Foxo1 dependent switch from T-bet to Eomesodermin transcription factor activation and increase in memory precursors ... The
Foxo1 inactivation was dependent on mTORC1 kinase, given that blockade of mTORC1 abrogated
mTORC2 mediated Akt ( Ser473 ) kinase phosphorylation, resulting in Foxo1 dependent switch from T-bet to Eomesodermin transcription factor activation and increase in memory precursors
Ikeda et al., J Pharmacol Sci 2013 (Adrenal Gland Neoplasms...) :
Indeed, direct
mTORC1 inhibition
initiates ULK1/2 autophosphorylation and subsequent Atg13 and
FIP200 phosphorylation, inducing autophagy ... Indeed, direct
mTORC1 inhibition
initiates ULK1/2 autophosphorylation and subsequent
Atg13 and FIP200 phosphorylation, inducing autophagy
Boletta , PathoGenetics 2009 :
The
mTORC1 complex regulates cell growth ( size ), proliferation, translation and autophagy, and
mTORC2 regulates the actin cytoskeleton and apoptosis
Esen et al., Cell Metab 2013 :
Deletion of
Lrp5 in the mouse, which decreases postnatal bone mass,
reduces mTORC2 activity and glycolytic enzymes in bone cells and lowers serum lactate levels
Lee et al., Genes Dev 2010 :
Collectively, these findings establish
mTOR/rictor mediated
Akt activation as a key driver of NSC proliferation and gliogenesis, and identify a unique mechanism for conferring brain region-specific responses to cancer causing genetic changes
Liu et al., Proc Natl Acad Sci U S A 2011 (Hypertelorism...) :
Increased
PP2A levels, resulting from proteasome inhibition or depletion of MID1, lead to disruption of the mTOR/Raptor complex and
down-regulated mTORC1 signaling
Wang et al., J Biol Chem 2008 :
Furthermore,
FKBP38 did not
inhibit mTORC1 signaling ... Reducing
TCTP levels did not reproducibly
affect mTORC1 signaling in amino acid-replete/insulin stimulated cells ... Our data also indicate that, in the mammalian cell lines tested here, neither
TCTP nor FKBP38
regulates mTORC1 signaling ... Our data also indicate that, in the mammalian cell lines tested here, neither TCTP nor
FKBP38 regulates
mTORC1 signaling
Chakrabarti et al., Diabetes 2010 :
Activation of
mTORC1 signaling in 3T3-L1 adipocytes by ectopic expression of Rheb
inhibits expression of ATGL and
HSL at the level of transcription, suppresses lipolysis, increases de novo lipogenesis, and promotes intracellular accumulation of triglycerides ...
Activation of
mTORC1 signaling in 3T3-L1 adipocytes by ectopic expression of
Rheb inhibits expression of ATGL and HSL at the level of transcription, suppresses lipolysis, increases de novo lipogenesis, and promotes intracellular accumulation of triglycerides
Zeng et al., Blood 2007 (Leukemia, Myeloid, Acute) :
Rapamycin derivatives reduce
mTORC2 signaling and
inhibit AKT activation in AML
Treins et al., Oncogene 2010 :
Rictor phosphorylation at Thr1135 does not
lead to major changes in
mTORC2-kinase activity
Han et al., Cell 2012 :
Here we show that
leucyl-tRNA synthetase (LRS) plays a critical role in amino acid induced
mTORC1 activation by sensing intracellular leucine concentration and initiating molecular events leading to mTORC1 activation
Kimball et al., J Biol Chem 2008 :
Rapid turnover of the
mTOR complex 1 (mTORC1) repressor REDD1 and
activation of
mTORC1 signaling following inhibition of protein synthesis
Kim et al., J Lipid Res 2010 :
GIP induced phospho-CREB and
TORC2 were shown to bind to a cAMP-response element ( -II ) site in the human LPL promoter and GIP increased protein-protein interactions of these two factors ... The lipogenic effects of GIP in the presence of insulin are therefore at least partially mediated by upregulation of adipocyte LPL gene transcription through a pathway involving
PI3-K/PKB/AMPK dependent
CREB/TORC2 activation ... The lipogenic effects of GIP in the presence of insulin are therefore at least partially mediated by upregulation of adipocyte LPL gene transcription through a pathway involving
PI3-K/PKB/AMPK dependent
CREB/TORC2 activation ... The lipogenic effects of GIP in the presence of insulin are therefore at least partially mediated by upregulation of adipocyte LPL gene transcription through a pathway involving
PI3-K/PKB/AMPK dependent
CREB/TORC2 activation
Matheny et al., Growth Factors 2012 :
Enhanced
Akt phosphorylation and myogenic differentiation in PI3K p110ß-deficient myoblasts is
mediated by PI3K p110a and
mTORC2
Park et al., Leukemia 2013 (Leukemia, Myeloid, Acute...) :
We conducted a phase Ib trial combining
RAD001 ( everolimus ), an allosteric
inhibitor of
mTORC1 , and conventional chemotherapy, in AML patients under 65 years of age at first relapse ( clinical trial NCT 01074086 )
Maru et al., J Urol 2013 (Carcinoma, Renal Cell...) :
We investigated whether
mTORC2 regulates
E-cadherin expression and controls cell motility during HIF-2a down-regulation in renal cell carcinoma cells ... Results show that
mTORC2 might
regulate E-cadherin expression and suppress cell motility by controlling the mTORC2-HIF-2a signaling pathway
Urbanska et al., J Biol Chem 2012 :
We also identified
Akt as a downstream effector of mTORC2 needed for proper dendritic arbor morphology, the action of which
required mTORC1 and p70S6K1
Zhao et al., Anat Rec (Hoboken) 2011 (Nasopharyngeal Neoplasms) :
AMPK mediated inhibition of
mTORC1 signaling may be involved in this process
Gustafson et al., Oncogene 2010 :
Phosphorylation of
Myc proteins is
controlled in-part by the receptor tyrosine kinase/phosphatidylinositol
3-kinase/Akt/mTOR signaling , with additional contributions from Aurora A kinase
Kurebayashi et al., Cell reports 2012 :
Inhibition of
PI3K-Akt-mTORC1-S6K1 axis
impairs the downregulation of
Gfi1 , a negative regulator of Th17 differentiation
Tatebe et al., Curr Biol 2010 :
Human Rab6 can substitute Ryh1 in S. pombe, and therefore
Rab6 may be a potential
activator of
TORC2 in mammals
Han et al., J Biol Chem 2012 :
Our results establish that
Pam regulates
TSC/mTOR signaling in vitro and in vivo through two distinct domains
Dormond et al., J Immunol 2008 (Inflammation...) :
CD40 induced signaling in human endothelial cells
results in
mTORC2- and Akt dependent expression of vascular endothelial growth factor in vitro and in vivo ... Also, rapamycin failed to inhibit VEGF promoter activation, as well as VEGF protein expression in EC transfected with a constitutively active construct of Akt, further demonstrating that
mTORC1 is not
necessary for
CD40- and Akt induced expression of VEGF
Wu et al., Urol Oncol 2012 (Carcinoma, Transitional Cell...) :
The present findings also suggest rictor dependent
AKT activation as a
consequence of
mTORC1 inhibition
Yoon et al., J Biol Chem 2011 :
This leads to PA antagonizing
FKBP38 inhibition of
mTORC1 kinase activity in vitro and rescuing mTORC1 signaling from FKBP38 in cells
Le Borgne et al., PloS one 2013 (Listeriosis...) :
Absence of kinase suppressor of Ras 1 (KSR1), a scaffold protein of the ERK signaling pathway, or inhibition of
ERK resulted in decreased
mTORC1 activity following T cell activation ... Absence of
kinase suppressor of Ras 1 (KSR1) , a scaffold protein of the ERK signaling pathway, or inhibition of ERK
resulted in decreased
mTORC1 activity following T cell activation
Hwang et al., BMB Rep 2011 (Ischemia) :
The loss of TSC2, which is upstream of mTOR, activates
S6K1 , promotes cell growth and survival, activates mTOR kinase activities,
inhibits mTORC1 and mTORC2 via mTOR inhibitors, and suppresses S6K1 and Akt ... The loss of TSC2, which is upstream of mTOR, activates S6K1, promotes cell growth and survival, activates mTOR kinase activities,
inhibits mTORC1 and
mTORC2 via mTOR inhibitors, and suppresses
S6K1 and Akt ... The loss of TSC2, which is upstream of mTOR, activates S6K1, promotes cell growth and survival, activates mTOR kinase activities,
inhibits mTORC1 and mTORC2 via mTOR inhibitors, and suppresses S6K1 and
Akt ... The loss of TSC2, which is upstream of mTOR, activates S6K1, promotes cell growth and survival, activates mTOR kinase activities,
inhibits mTORC1 and
mTORC2 via mTOR inhibitors, and suppresses S6K1 and
Akt ... The loss of TSC2, which is upstream of mTOR, activates S6K1, promotes cell growth and survival, activates
mTOR kinase activities,
inhibits mTORC1 and mTORC2 via mTOR inhibitors, and suppresses S6K1 and Akt ... The loss of TSC2, which is upstream of mTOR, activates S6K1, promotes cell growth and survival, activates
mTOR kinase activities,
inhibits mTORC1 and
mTORC2 via mTOR inhibitors, and suppresses S6K1 and Akt ... The loss of
TSC2 , which is upstream of mTOR, activates S6K1, promotes cell growth and survival, activates mTOR kinase activities,
inhibits mTORC1 and
mTORC2 via mTOR inhibitors, and suppresses S6K1 and Akt ... The loss of
TSC2 , which is upstream of mTOR, activates S6K1, promotes cell growth and survival, activates mTOR kinase activities,
inhibits mTORC1 and mTORC2 via mTOR inhibitors, and suppresses S6K1 and Akt
Pajvani et al., Nat Med 2013 (Body Weight...) :
We demonstrate that
Notch signaling
increases mTorc1 complex stability, augmenting mTorc1 function and sterol regulatory element binding transcription factor 1c ( Srebp1c ) -mediated lipogenesis
Piao et al., Biochem Biophys Res Commun 2009 :
Reciprocally, the
mTORC1 dependent phosphorylation of
FLCN was reported
Thiem et al., J Clin Invest 2013 (Disease Models, Animal...) :
We analyzed the mechanism of
GP130 mediated
mTORC1 activation in cells and mice and revealed a requirement for JAK and PI3K activity but not for GP130 tyrosine phosphorylation or STAT3
Wu et al., J Biol Chem 2011 :
The p38ß-PRAK cascade targets
Rheb to
inhibit mTORC1 activity upon glucose depletion ... The phosphorylation of
Raptor on these sites
enhances mTORC1 activity, and contributes largely to arsenite induced mTORC1 activation ... The phosphorylation of
Raptor on these sites enhances mTORC1 activity, and
contributes largely to arsenite induced
mTORC1 activation
Ost et al., Mol Med 2010 (Diabetes Mellitus, Type 2...) :
Conversely, mitochondrial dysfunction attenuated
insulin activation of
mTORC1 , enhanced autophagy and attenuated feedback to IRS1
Yecies et al., Cell Metab 2011 :
To further define the
role of
mTORC1 in the regulation of
SREBP1c in the liver, we generated mice with liver-specific deletion of TSC1 ( LTsc1KO ), which results in insulin independent activation of mTORC1 ... Therefore,
mTORC1 activation is not
sufficient to stimulate hepatic
SREBP1c in the absence of Akt signaling, revealing the existence of an additional downstream pathway also required for this induction
Espona-Fiedler et al., Biochem Pharmacol 2012 (Melanoma) :
The inhibition of mTORC1 and
mTORC2 complexes by PG or OBX
resulted in a loss of
AKT phosphorylation at S473, preventing its full activation, with no significant effect on T308 ... The inhibition of
mTORC1 and mTORC2 complexes by PG or OBX
resulted in a loss of
AKT phosphorylation at S473, preventing its full activation, with no significant effect on T308
Lee et al., Immunity 2010 :
mTORC2 promoted phosphorylation of
protein kinase B ( PKB, or Akt ) and PKC, Akt activity, and nuclear NF-kappaB transcription factors in response to T cell activation
Liu et al., J Biol Chem 2010 :
Taken together, our studies reveal that RSV
inhibits leucine stimulated
mTORC1 activation by promoting
mTOR/DEPTOR interaction and thus uncover a novel mechanism by which RSV negatively regulates mTOR activity ... Taken together, our studies reveal that RSV
inhibits leucine stimulated
mTORC1 activation by promoting
mTOR/DEPTOR interaction and thus uncover a novel mechanism by which RSV negatively regulates mTOR activity
Lipinski et al., Dev Cell 2010 (MAP Kinase Signaling System) :
In a genome-wide human siRNA screen, we demonstrate that under normal nutrient conditions upregulation of autophagy requires the type III
PI3 kinase, but not
inhibition of
mTORC1 , the essential negative regulator of starvation induced autophagy
Zhao et al., Mol Cell 2011 :
DEPTOR , an
inhibitor of mTORC1 and
mTORC2 , is degraded via ubiquitin-proteasome pathway by an unknown E3 ubiquitin ligase ...
DEPTOR , an
inhibitor of
mTORC1 and mTORC2, is degraded via ubiquitin-proteasome pathway by an unknown E3 ubiquitin ligase
Wang et al., J Biol Chem 2007 :
In
response to
insulin and nutrients,
mTORC1 , consisting of mTOR, raptor ( regulatory associated protein of mTOR ), and mLST8, is activated and phosphorylates eukaryotic initiation factor 4E-binding protein ( 4EBP ) and p70 S6 kinase to promote protein synthesis and cell size
Dibble et al., Mol Cell Biol 2009 :
We find that Rictor-T1135 is directly phosphorylated by the
mTORC1 dependent kinase
S6K1 ... Although this phosphorylation event does not affect mTORC2 integrity or in vitro kinase activity, expression of a phosphorylation site mutant of Rictor ( T1135A ) in either wild-type or Rictor null cells causes an increase in the
mTORC2 dependent phosphorylation of
Akt on S473 ... However, Rictor-T1135 phosphorylation does not appear to regulate
mTORC2 mediated effects on
SGK1 or PKC alpha ... However, Rictor-T1135 phosphorylation does not appear to regulate
mTORC2 mediated effects on SGK1 or
PKC alpha
Csibi et al., Cell 2013 (Neoplasms) :
Mechanistically,
mTORC1 represses
SIRT4 by promoting the proteasome mediated destabilization of cAMP-responsive element binding 2 ( CREB2 )
Averous et al., Oncogene 2008 (Breast Neoplasms) :
Regulation of
cyclin D1 expression by
mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1
Mazhab-Jafari et al., Structure 2012 :
We demonstrate that the opposing functions of
Tyr35 in the intrinsic and GAP stimulated GTP catalysis are
critical for optimal
mTORC1 regulation
Chai et al., Peptides 2010 :
MC4R activation potentiates
insulin stimulated
mTOR signaling via the AMPK pathway
White et al., Am J Physiol Endocrinol Metab 2013 (Cachexia...) :
Muscle
mTORC1 suppression by IL-6 during cancer cachexia : a
role for
AMPK ... How
IL-6 can
induce suppression of
mTORC1 signaling remains to be established
Rothbart et al., Cancer Res 2010 :
Whereas
AMPK activation
resulted in marked inhibition of
mTORC1 , other targets of AMPK were phosphorylated that were not mTORC1 dependent
Koyanagi et al., PloS one 2011 :
Activation of
mTORC1 by
TSC2 ablation increases mitochondrial biogenesis and enhances insulin secretion from pancreatic beta cells ... Activation of
mTORC1 by TSC2 ablation increases mitochondrial biogenesis and
enhances insulin secretion from pancreatic beta cells
Shu et al., Mol Biol Cell 2012 :
Synthesis of cAMP receptor and adenylyl cyclase A ( ACA ) is inhibited, and activation of ACA, RasC, and RasG, phosphorylation of
extracellular signal regulated kinase 2 ,
activation of
TORC2 , and stimulation of actin polymerization and myosin assembly are greatly reduced ... Synthesis of cAMP receptor and adenylyl cyclase A ( ACA ) is inhibited, and activation of ACA, RasC, and RasG, phosphorylation of extracellular signal regulated kinase 2,
activation of
TORC2 , and stimulation of actin polymerization and
myosin assembly are greatly reduced
Castets et al., Cell Metab 2013 :
In young TSCmKO mice, constitutive and starvation induced autophagy is blocked at the induction steps via
mTORC1 mediated inhibition of
Ulk1 , despite FoxO3 activation
Ethier et al., PloS one 2012 (Necrosis) :
In this study, we show that
PARP-1 activation and PAR synthesis affect the energetic status of cells, inhibit the mTORC1 signaling pathway and possibly
modulate the
mTORC2 complex affecting cell fate
Rosel et al., J Cell Sci 2012 :
TORC1 is required for growth in response to growth factors, nutrients and the cellular energy state ;
TORC2 regulates
AKT signaling, which can modulate cytoskeletal polarization
Astle et al., Oncogene 2012 (Cell Transformation, Neoplastic) :
We demonstrate that AKT induced senescence is p53 dependent and is characterised by
mTORC1 dependent regulation of
p53 translation and stabilisation of p53 protein following nucleolar localisation and inactivation of MDM2
Vu et al., Clin Cancer Res 2010 (Leukemia...) :
The majority of preclinical and clinical efforts to target TOR have involved using rapamycin and its analogs ( rapalogs ), which suppress
TORC1 only partially and do not acutely
inhibit TORC2
Kato et al., PloS one 2013 :
Knockdown of
Raptor , a positive
regulator of
mTORC1 , also had the similar effect ... Knockdown of
TSC2 , a negative
regulator of
mTORC1 , caused activation of mTORC1 and enhanced Cd induction of the IRE1-JNK pathway and apoptosis without affecting other UPR branches
Ramírez-Rangel et al., Mol Cell Biol 2011 :
GRp58/ERp57 knockdown reduces
mTORC1 levels and phosphorylation of 4E-BP1 and p70 ( S6K ) in
response to
insulin ... In contrast,
GRp58/ERp57 overexpression
increases mTORC1 levels and activity ... In contrast,
GRp58/ERp57 overexpression
increases mTORC1 levels and activity
Grosso et al., PloS one 2011 :
In spite of this,
mTORc1 inhibition
reduces eIF4F complex formation, and depresses translocation of TOP mRNAs on polysomes
Pang et al., World J Gastroenterol 2013 :
Furthermore, TM treatment also activated
mTORC1 , and in turn reduced
Akt phosphorylation, which suggested the PI3K/Akt/mTOR signal pathway was
involved in the TM-induced autophagic response in EC109 cells
Pollizzi et al., Molecular cancer 2009 (Disease Models, Animal...) :
Loss of either
TSC1 or TSC2 in TSC hamartomas
leads to activation of
mTORC1 and suppression of AKT ... Loss of either TSC1 or
TSC2 in TSC hamartomas
leads to activation of
mTORC1 and suppression of AKT ... Recent studies indicate that inhibition of
mTORC1 with RAD001 ( everolimus )
leads to rebound activation of
AKT , which could protect tumors from drug induced cell death
Lu et al., Blood 2013 (Multiple Myeloma) :
We identify
TSC2 , a negative
regulator of
mTOR-C1 , as a novel Pim2 substrate and show that Pim2 directly phosphorylates TSC2 on Ser-1798 and relieves the suppression of TSC2 on mTOR-C1
Sciarretta et al., Circulation 2012 (Metabolic Syndrome X...) :
Rheb inhibition
causes mTORC1 inhibition, because forced activation of Rheb, through Rheb overexpression in vitro and through inducible cardiac-specific Rheb overexpression in vivo, restored mTORC1 activity ... Restoration of autophagy, through
Atg7 reexpression and
inhibition of
mTORC1 , increased cellular ATP content and reduced endoplasmic reticulum stress, thereby reducing CM death induced by Rheb activation
Real et al., PloS one 2011 :
The
activation of cell growth and
mTORC1 by
E2F1 is dependent on both E2F1 's ability to bind DNA and to regulate gene transcription, demonstrating that a gene induction expression program is required in this process ... The
effect of
E2F1 on the activation of
mTORC1 does not depend on Akt ... Immunolocalization studies demonstrate that
E2F1 induces the translocation of
mTORC1 to the late endosome vesicles, in a mechanism dependent of leucine
Kladney et al., Cancer Res 2010 (Prostatic Intraepithelial Neoplasia...) :
Here, we engineered constitutive mTORC1 activation in prostate epithelium by a conditional genetic deletion of
tuberous sclerosis complex 1 (Tsc1) , a potent negative
regulator of
mTORC1 signaling
Shortt et al., Blood 2013 (Lymphoma, B-Cell) :
Moreover, apoptosis was initiated at drug concentrations insufficient to antagonize
PI3K/mTORC2 regulated
AKT phosphorylation
Vadlakonda et al., Frontiers in oncology 2013 :
We present in this article, a hypothesis that activation of
Akt-T308 phosphorylation in the presence of high ATP : AMP ratio promotes the stability of its phosphorylations and
activates mTORC1 and the energy consuming biosynthetic processes
Lee et al., PloS one 2010 (Endotoxemia) :
Furthermore, in vitro cellular studies demonstrated that LPS ( lipopolysaccharide ) activation of
mTORC1-S6K still occurs in the
presence of
PI3K-Akt inhibition alone, but can be suppressed by concurrent inhibition of PI3K-Akt and MEK-ERK pathways ... Furthermore, in vitro cellular studies demonstrated that LPS ( lipopolysaccharide ) activation of
mTORC1-S6K still occurs in the
presence of
PI3K-Akt inhibition alone, but can be suppressed by concurrent inhibition of PI3K-Akt and MEK-ERK pathways ... Furthermore, in vitro cellular studies demonstrated that
LPS ( lipopolysaccharide )
activation of
mTORC1-S6K still occurs in the presence of PI3K-Akt inhibition alone, but can be suppressed by concurrent inhibition of PI3K-Akt and MEK-ERK pathways
Patel et al., J Oral Pathol Med 2013 (Carcinoma, Squamous Cell...) :
Indeed, inhibition of
OCT-3 expression and activity in HNSCC cells
prevented metformin induced AMP activated protein kinase activation and
mTORC1 pathway inhibition
Yu et al., Cancer Res 2010 (Neoplasms) :
Importantly, consistent with genetic ablation of mTORC2, WYE-132 targeted P-AKT ( S473 ) and AKT function without significantly reducing the steady-state level of the PI3K/PDK1 activity biomarker P-AKT ( T308 ), highlighting a prominent and direct
regulation of
AKT by
mTORC2 in cancer cells
Elmasri et al., Angiogenesis 2012 :
FABP4 was strongly
regulated by
mTORC1 and inhibited by Rapamycin
Tzatsos et al., J Biol Chem 2007 :
Energy depletion activates AMP activated protein kinase (AMPK) and inhibits cell growth via
TSC2 dependent suppression of
mTORC1 signaling
Sini et al., Autophagy 2010 (Neoplasms) :
mTORC1 activates
p70S6K , which in turn phosphorylates the ribosomal protein S6 and 4E-BP1, both involved in protein translation ...
mTORC2 activates
AKT directly by phosphorylating Serine 473
Zhao et al., Neoplasia (New York, N.Y.) 2012 (Neoplasms) :
Recently, we and others found that
DEPTOR , a naturally occurring
inhibitor of both mTORC1 and
mTORC2 , was degraded by SCF ( Skp1-Cullin-F box proteins ) E3 ubiquitin ligase, the founding member of cullin-RING-ligases ( CRLs ), resulting in mTOR activation and cell proliferation ... Recently, we and others found that
DEPTOR , a naturally occurring
inhibitor of both
mTORC1 and mTORC2, was degraded by SCF ( Skp1-Cullin-F box proteins ) E3 ubiquitin ligase, the founding member of cullin-RING-ligases ( CRLs ), resulting in mTOR activation and cell proliferation
Kamimura et al., Curr Biol 2008 :
Here, we outline a PIP ( 3 ) -independent pathway linking temporal and spatial
activation of
PKBs by
Tor complex 2 (TorC2) to the chemotactic response
Ai et al., J Clin Invest 2012 (Hyperinsulinism...) :
Regulation of hepatic
LDL receptors by
mTORC1 and PCSK9 in mice ... Pcsk9 is regulated by the transcription factor HNF1a, and our further detailed analyses suggest that increased
mTORC1 activity leads to activation of PKCd, reduced activity of HNF4a and HNF1a, decreased PCSK9 expression, and ultimately
increased hepatic
LDLR protein levels, which result in decreased circulating LDL levels
Cao et al., Science signaling 2009 :
Overall, this study suggests that Galpha ( i1 ) and Galpha ( i3 ) lie downstream of EGFR, but upstream of
Gab1 mediated activation of Akt and
mTORC1 , thus revealing a role for Galpha ( i ) proteins in mediating EGFR signaling
Pan et al., J Immunol 2013 :
Its deficiency in
DCs results in increased mammalian target of rapamycin (mTOR) complex 1 but decreased
mTORC2 signaling, altered cytokine production, impaired CIITA/MHC-II expression, and defective Ag presentation to CD4 T cells after TLR4 stimulation
Melnik et al., Exp Dermatol 2013 :
This hypothesis postulates that antiacne agents either enhance nuclear
FoxO activity or
inhibit mTORC1 ... Suppression of TNFa signalling by tetracyclines, erythromycin and other macrolides may attenuate
IKKß-TSC1 mediated
mTORC1 activation ... Antiandrogens may attenuate mTORC1 by suppressing
mTORC2 mediated
Akt/TSC2 signalling ... Antiandrogens may attenuate mTORC1 by suppressing
mTORC2 mediated
Akt/TSC2 signalling
Dunlop et al., Autophagy 2011 :
ULK1 inhibits
mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding ... ULK1 inhibits
mTORC1 signaling,
promotes multisite
Raptor phosphorylation and hinders substrate binding ... Interestingly,
ULK1 overexpression also increases phosphorylation of Raptor Ser863 and the mTOR autophosphorylation site, Ser2481 in a
mTORC1 dependent manner ... Interestingly,
ULK1 overexpression also increases phosphorylation of Raptor Ser863 and the mTOR autophosphorylation site, Ser2481 in a
mTORC1 dependent manner ... Despite this evidence for heightened mTORC1 kinase activity following ULK1 overexpresssion,
mTORC1 mediated phosphorylation of
S6K1 and 4E-BP1 is significantly inhibited ... Despite this evidence for heightened mTORC1 kinase activity following ULK1 overexpresssion,
mTORC1 mediated phosphorylation of S6K1 and
4E-BP1 is significantly inhibited ... We propose a new mechanism whereby
ULK1 contributes to
mTORC1 inhibition through hindrance of substrate docking to Raptor
Harwood et al., J Biol Chem 2008 (MAP Kinase Signaling System) :
mTORC1 signaling can
regulate growth factor activation of
p44/42 mitogen activated protein kinases through protein phosphatase 2A ...
mTORC1 signaling can
regulate growth factor activation of
p44/42 mitogen activated protein kinases through protein phosphatase 2A ... However, a
role for
mTORC1 signaling in modulating activation of
p44/42 has not been reported ... However, a
role for
mTORC1 signaling in modulating activation of
p44/42 has not been reported
Zheng et al., Nat Cell Biol 2011 :
Phosphorylation of
Rheb at Ser 130 by PRAK impairs the nucleotide binding ability of Rheb and
inhibits Rheb mediated
mTORC1 activation
Karni et al., Proc Natl Acad Sci U S A 2008 :
mTORC1 activation by
SF2/ASF bypasses upstream PI3K/Akt signaling and is essential for SF2/ASF mediated transformation, as inhibition of mTOR by rapamycin blocked transformation by SF2/ASF in vitro and in vivo
Yan et al., Mol Cell 2010 :
We identify a transautophosphorylation site in the MAP4K3 kinase activation segment ( Ser170 ) that is required for
MAP4K3 activity and its
activation of
mTORC1 signaling ... We propose that during amino acid sufficiency Ser170 phosphorylated
MAP4K3 activates
mTORC1 , but that upon amino acid restriction MAP4K3 preferentially interacts with PP2A ( T61 epsilon ), promoting dephosphorylation of Ser170, MAP4K3 inhibition, and, subsequently, inhibition of mTORC1 signaling
Rahimi et al., Cancer Res 2009 :
mTORC2 promotes TGF-beta induced morphologic transformation and is
required for TGF-beta induced Akt S473 phosphorylation but not
mTORC1 activation
Pistollato et al., PloS one 2009 (Brain Neoplasms...) :
Here, we investigate the
role of
mTOR signaling in the regulation of
HIF-1alpha stability in primary GBM derived cells maintained under hypoxia ( 2 % oxygen )
Origanti et al., Biochem J 2012 (Cell Transformation, Neoplastic) :
Inhibition of
mTORC1 also
reduced the association of the mRNA binding protein
HuR with the ODC transcript
Yang et al., Cell cycle (Georgetown, Tex.) 2010 (Neoplasms) :
Akt activity is well-known
regulated through its phosphorylation at T308 and S473 by PDK1 and
mTOrC2 , respectively
Floc'h et al., Cancer Res 2012 (Disease Models, Animal...) :
In human prostate cancer cell lines, although not in the mouse model, the synergistic actions of MK-2206 and ridaforolimus ( MK-8669 ) are due in part to limiting the
mTORC2 feedback
activation of
Akt
Ji et al., Oncogene 2010 (Neoplasms) :
Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin induced apoptosis by promoting
AMPK activation and
mTORC1 inhibition
Fortress et al., Learn Mem 2013 (MAP Kinase Signaling System) :
Here, we asked whether the enhancement of object recognition memory consolidation produced by dorsal hippocampal infusion of 17ß-estradiol ( E ( 2 ) ) is dependent on mTOR signaling in the dorsal hippocampus, and whether E ( 2 ) -induced
mTOR signaling is
dependent on dorsal hippocampal
phosphatidylinositol 3-kinase (PI3K) and extracellular signal regulated kinase ( ERK ) activation
Shen et al., International journal of clinical and experimental pathology 2010 (Carcinoma, Endometrioid...) :
mTORC1 and mTORC2 phosphorylatively
regulate their respective downstream effectors
p70S6K/4EBP1 , and Akt ... mTORC1 and
mTORC2 phosphorylatively
regulate their respective downstream effectors
p70S6K/4EBP1 , and Akt ... mTORC1 and
mTORC2 phosphorylatively
regulate their respective downstream effectors
p70S6K/4EBP1 , and Akt ...
mTORC1 and mTORC2 phosphorylatively
regulate their respective downstream effectors
p70S6K/4EBP1 , and Akt ...
mTORC1 and mTORC2 phosphorylatively
regulate their respective downstream effectors
p70S6K/4EBP1 , and Akt ... mTORC1 and
mTORC2 phosphorylatively
regulate their respective downstream effectors
p70S6K/4EBP1 , and Akt
Phu et al., Cell Signal 2011 :
Overexpressed
DLK induced the phosphorylation of
TORC2 and TORC1 on Ser-171 and 167, respectively and on additional residues
Vojtechová et al., Neoplasia (New York, N.Y.) 2008 :
Regulation of
mTORC1 signaling by
Src kinase activity is Akt1 independent in RSV transformed cells
Han et al., Clin Cancer Res 2009 (Chordoma) :
Strikingly, expression of
PTEN , a negative
regulator of
mTORC1 signaling, was not detected or significantly reduced in chordoma derived cell lines and primary tumors
Tanwar et al., PLoS Genet 2012 (Adenoma...) :
Deletion of the genes for
Tuberous Sclerosis 1 (Tsc1) or Tsc2,
regulators of
mTORC1 that are downstream of LKB1 signaling, in the oviductal and uterine stroma phenocopies some of the defects observed in Lkb1 mutant mice, confirming that dysregulated mTORC1 activation in the Lkb1 deleted stroma contributes to the phenotype ... Deletion of the genes for Tuberous Sclerosis 1 (Tsc1) or
Tsc2 ,
regulators of
mTORC1 that are downstream of LKB1 signaling, in the oviductal and uterine stroma phenocopies some of the defects observed in Lkb1 mutant mice, confirming that dysregulated mTORC1 activation in the Lkb1 deleted stroma contributes to the phenotype ... Loss of
PTEN , an upstream
regulator of
mTORC1 signaling, along with Lkb1 deletion significantly increased tumor burden in uteri and induced tumorigenesis in the cervix and vagina
Willems et al., Leukemia 2012 (Leukemia, Myeloid, Acute) :
In addition, the
mTORC1 dependent
PI3K/Akt feedback activation was fully abrogated in AZD8055 treated AML cells ... In addition, the
mTORC1 dependent
PI3K/Akt feedback
activation was fully abrogated in AZD8055 treated AML cells
Zhang et al., Free Radic Biol Med 2009 :
In this study we report the effect of H ( 2 ) O ( 2 ) on
insulin stimulated
mTORC1 activity and assembly using A549 and bovine aortic smooth muscle cells ... These findings are consistent with PRAS40 functioning as a negative regulator of
insulin stimulated
mTORC1 activity during oxidant stress
Jaba et al., J Clin Invest 2013 :
NOS inhibitor L-NAME also significantly attenuated RGS4 degradation, and
reduced activation of
AKT/mTORC1 signaling and induction of myocardial hypertrophy in PlGF transgenic mice, while conditional cardiac-specific PlGF expression in eNOS knockout mice did not induce myocardial hypertrophy
Stevens et al., J Biol Chem 2009 :
Peptide combinatorial libraries identify TSC2 as a death associated protein kinase ( DAPK ) death domain binding protein and reveal a stimulatory
role for
DAPK in
mTORC1 signaling ... DAPK ( +/- ) mouse embryo fibroblasts have attenuated
mTORC1 signaling compared with DAPK+/+ counterparts, and overexpression of
DAPK in DAPK ( +/- ) MEFs
stimulates mTORC1 activity ... DAPK ( +/- ) mouse embryo fibroblasts have attenuated mTORC1 signaling compared with DAPK+/+ counterparts, and overexpression of
DAPK in DAPK ( +/- ) MEFs
stimulates mTORC1 activity
Li et al., Cell Signal 2010 :
These data suggest that
PP2A and AMPK mediated phosphorylation of Raptor
mediate H ( 2 ) O ( 2 ) -induced inhibition of
mTORC1 signaling
Jaafar et al., J Biol Chem 2011 :
Vasopressin stimulation also induced phosphorylation of Akt on Ser-473 through
PLD1 dependent activation of
mTORC2 complex
Lorne et al., Am J Respir Cell Mol Biol 2009 (Acute Lung Injury) :
Rapamycin pretreatment inhibited PAM- or
LPS induced
mTORC1 activation in the lungs
Kumar et al., Mol Cell Biol 2008 :
Since little is known about the
role of either rictor or
mTORC2 in
PI-3 kinase mediated physiological processes in adult animals, we generated muscle-specific rictor knockout mice
O'Brien et al., Arch Immunol Ther Exp (Warsz) 2012 (MAP Kinase Signaling System) :
Furthermore, we highlight the importance of tight control of mTOR signaling by
tuberous sclerosis complex 1 for T-cell homeostasis, and the
regulation of
mTOR signaling by diacylglycerol kinases and the RasGRP1-Ras-Erk1/2 pathway in the context of TCR signaling ... Furthermore, we highlight the importance of tight control of mTOR signaling by tuberous sclerosis complex 1 for T-cell homeostasis, and the
regulation of
mTOR signaling by diacylglycerol kinases and the
RasGRP1-Ras-Erk1/2 pathway in the context of TCR signaling ... Furthermore, we highlight the importance of tight control of mTOR signaling by tuberous sclerosis complex 1 for T-cell homeostasis, and the
regulation of
mTOR signaling by diacylglycerol kinases and the
RasGRP1-Ras-Erk1/2 pathway in the context of TCR signaling
Sato et al., J Biol Chem 2009 :
The
activation of
mTORC1 by
Rheb can be faithfully reproduced in vitro by using mTORC1 immunoprecipitated by the use of anti-raptor antibody from mammalian cells starved for nutrients ... Both
Rheb1 and Rheb2
activate mTORC1 ... Both Rheb1 and
Rheb2 activate
mTORC1 ... FKBP38, a recently proposed mediator of Rheb action, appears not to be involved in the
Rheb dependent activation of
mTORC1 in vitro, because the preparation of mTORC1 that is devoid of FKBP38 is still activated by Rheb ... PRAS40, a TOR signaling ( TOS ) motif containing protein that competes with the binding of 4EBP1 to mTORC1, inhibits
Rheb induced activation of
mTORC1
Wolin , Cancer Lett 2013 (Neuroendocrine Tumors...) :
The mTOR inhibitor everolimus has been approved by the FDA for the treatment of pNET, but its efficacy may be limited by its inability to prevent
mTORC2 mediated activation of
Akt
Finlay , Biochem Soc Trans 2013 :
mTORC1 regulates glucose metabolism in CTLs through regulating the expression of the transcription factor
HIF1a ( hypoxia-inducible factor 1a )
Marzec et al., PloS one 2011 (Lymphoma, T-Cell, Cutaneous) :
mTORC1 activates p70S6kinase 1 (p70S6K1) and
inhibits 4E-binding protein 1 (4E-BP1) ...
mTORC1 activates
p70S6kinase 1 (p70S6K1) and inhibits 4E-binding protein 1 (4E-BP1)
Audhya et al., EMBO J 2004 :
Consistent with these findings, phosphorylation of
Slm1 and Slm2 was
dependent on
TORC2 protein kinase activity, both in vivo and in vitro, and Slm1 localization required both PI4,5P ( 2 ) and functional TORC2 ... Consistent with these findings, phosphorylation of Slm1 and
Slm2 was
dependent on
TORC2 protein kinase activity, both in vivo and in vitro, and Slm1 localization required both PI4,5P ( 2 ) and functional TORC2
Kato et al., Cell Death Differ 2012 (MAP Kinase Signaling System) :
Activation of
mTORC1 reduced
Akt phosphorylation, which was an event upstream of IRE-JNK signaling and consequent apoptosis ... These results disclosed that, under ER stress conditions,
mTORC1 causes apoptosis through suppression of
Akt and consequent induction of the IRE1-JNK pathway
Wagner et al., Am J Physiol Cell Physiol 2010 :
Rheb overexpression
induced mTORC1 activity and repressed contractile protein expression, but a farnesylation-deficient mutant ( C18S ) elicited the opposite effect ... Notably,
mTORC1 activity was elevated in VSMC isolated from an intimal hyperplastic patient lesion compared with normal media, and lovastatin treatment
inhibited mTORC1 activity in these cultures
Cam et al., Mol Cell 2010 :
mTORC1 signaling under hypoxic conditions is
controlled by ATM dependent phosphorylation of
HIF-1a
Ohmae et al., J Biol Chem 2006 :
Although these were previously shown to activate Ca ( 2+ ) /cAMP-response element binding protein ( CREB ) -dependent transcription, we here show that CL1 and CL2 were unable to significantly phosphorylate CREB Ser-133 and rather inhibited CRE dependent gene expression by a dominant mechanism that bypassed
CREB and was
mediated by phosphorylated
TORC2
Magee et al., Cell stem cell 2012 (Leukemia) :
Pten is therefore
required in adult, but not neonatal, HSCs to negatively regulate
mTORC2 signaling
Lee et al., Oncogene 2012 (Carcinoma, Non-Small-Cell Lung...) :
This demonstrates that the pro-oncogenic activity of TR3 in lung cancer cells was due to inhibition of
p53 and
activation of
mTORC1
Koh et al., Endocr Relat Cancer 2012 (Carcinoma...) :
Cells treated with everolimus demonstrated
activation of
Akt and Ret via
TORC2 complex dependent and TORC2 complex independent mechanisms respectively ... Cells treated with everolimus demonstrated
activation of Akt and
Ret via
TORC2 complex dependent and TORC2 complex independent mechanisms respectively
Vega-Rubin-de-Celis et al., Biochemistry 2010 :
REDD1 is induced by hypoxia, and
REDD1 overexpression is
sufficient to inhibit
mTORC1 ...
mTORC1 is
regulated by the small GTPase
Rheb , which in turn is regulated by the GTPase activating protein complex, TSC1/TSC2 ... REDD1
induced-mTORC1 inhibition
requires the
TSC1/TSC2 complex , and REDD1 has been proposed to act by directly binding to and sequestering 14-3-3 proteins away from TSC2 leading to TSC2 dependent inhibition of mTORC1 ...
REDD1 induced-mTORC1 inhibition requires the TSC1/TSC2 complex, and REDD1 has been proposed to act by directly binding to and sequestering 14-3-3 proteins away from TSC2 leading to TSC2 dependent inhibition of mTORC1 ... REDD1 induced-mTORC1 inhibition requires the TSC1/TSC2 complex, and REDD1 has been proposed to act by directly binding to and sequestering 14-3-3 proteins away from TSC2 leading to
TSC2 dependent inhibition of
mTORC1 ... Sequence conservation mapping to the surface of the structure and mutagenesis studies demarcated a hotspot likely to interact with effector proteins that is essential for
REDD1 mediated
mTORC1 inhibition
Laplante et al., Cell Metab 2012 (Obesity) :
DEPTOR activates the proadipogenic Akt/PKB-PPAR-? axis by dampening
mTORC1 mediated feedback inhibition of
insulin signaling
Dennis et al., J Biol Chem 2011 :
Mechanisms involved in the coordinate
regulation of
mTORC1 by
insulin and amino acids ... In this study, we explored the coordinate
regulation of
mTORC1 by
insulin and amino acids ... In deprived cells,
mTORC1 was
activated by expressing either constitutively active ( ca )
Rheb or a caRagB·caRagC complex, and coexpression of the constructs had an additive effect
Wang et al., J Biol Chem 2009 :
Inhibition of mTORC1 or mTORC2 by transiently or moderately activated MEK/ERK caused moderately enhanced Beclin 1 resulting in cytoprotective autophagy, whereas inhibition of both mTORC1 and
mTORC2 by sustained MEK/ERK activation
caused strongly pronounced
Beclin 1 leading to cytodestructive autophagy ... Inhibition of
mTORC1 or mTORC2 by transiently or moderately activated MEK/ERK
caused moderately enhanced
Beclin 1 resulting in cytoprotective autophagy, whereas inhibition of both mTORC1 and mTORC2 by sustained MEK/ERK activation caused strongly pronounced Beclin 1 leading to cytodestructive autophagy ... Inhibition of mTORC1 or mTORC2 by transiently or moderately activated MEK/ERK caused moderately enhanced Beclin 1 resulting in cytoprotective autophagy, whereas inhibition of both
mTORC1 and mTORC2 by sustained MEK/ERK activation
caused strongly pronounced
Beclin 1 leading to cytodestructive autophagy
Lyo et al., Biochem Biophys Res Commun 2010 (Kidney Neoplasms) :
We report here that the PLD/mTOR dependent stabilization of
HDM2 involves
mTORC2 and the AGC family kinase serum- and glucocorticoid-inducible kinase 1 ( SGK1 )
Lishner et al., Cell Signal 2008 (Multiple Myeloma) :
Herein we demonstrate that the anti-myeloma
effect of
CD81/CD82 involves a down-regulation of Akt, activation of FoxO transcription factors and a decrease in active mTOR and
mTOR/rictor ... Herein we demonstrate that the anti-myeloma
effect of
CD81/CD82 involves a down-regulation of Akt, activation of FoxO transcription factors and a decrease in active mTOR and
mTOR/rictor
Kim et al., J Biol Chem 2010 (Breast Neoplasms...) :
In contrast,
API-1 had no effects on the activities of the upstream Akt activators, phosphatidylinositol 3-kinase, phosphatidylinositol dependent kinase-1, and
mTORC2
Zeng et al., Nature 2013 (Inflammation) :
By contrast,
mTORC1 does not directly
affect the expression of
Foxp3 or anti- and pro-inflammatory cytokines in T ( reg ) cells, suggesting a non-conventional mechanism for T ( reg ) -cell functional regulation
Saci et al., Mol Cell 2011 :
Rac1 regulates the activity of
mTORC1 and mTORC2 and controls cellular size ...
Rac1 regulates the activity of mTORC1 and
mTORC2 and controls cellular size
Zha et al., Cancer Lett 2011 (Cell Transformation, Neoplastic) :
Here we present evidence for the involvement of STAT3, a known
mTORC1 regulated
transcription factor , in this process
Ekim et al., Mol Cell Biol 2011 :
mTOR kinase domain phosphorylation
promotes mTORC1 signaling, cell growth, and cell cycle progression
Wang et al., J Biol Chem 2009 :
Raptor ( regulatory associated protein of mammalian target of rapamycin (mTOR) ), a constitutively binding protein of mTORC1, is
essential for
mTORC1 activity and critical for the regulation of mTORC1 activity in response to insulin signaling and nutrient and energy sufficiency ... Raptor ( regulatory associated protein of mammalian target of rapamycin (mTOR) ), a constitutively binding protein of mTORC1, is essential for mTORC1 activity and critical for the regulation of
mTORC1 activity in
response to
insulin signaling and nutrient and energy sufficiency
Fang et al., J Biol Chem 2012 (Prostatic Neoplasms) :
Significantly, androgen increased
TORC2 mediated
AKT S473 phosphorylation without affecting the PDK1 mediated AKT T308 phosphorylation or TORC1 activity ... This study reveals a pathway linking AR to a selective activation of
TORC2 , the subsequent
activation of
AKT , and phosphorylation of a discrete set of AKT substrates that regulate cellular proliferation and survival
Yoon et al., J Cell Sci 2008 :
Instead,
PLD1 positively
regulates mTOR signaling leading to the production of IGF2, an autocrine factor instrumental for the initiation of satellite cell differentiation ... Instead,
PLD1 positively
regulates mTOR signaling leading to the production of IGF2, an autocrine factor instrumental for the initiation of satellite cell differentiation
Bentzinger et al., Cell Metab 2008 (Muscular Dystrophies) :
Finally, we show that activation of
PKB/Akt does not
require mTORC2 ... Finally, we show that activation of
PKB/Akt does not
require mTORC2
Chakrabarti et al., Mol Endocrinol 2008 :
The activity of
mTORC1 in 3T3-L1 adipocytes was
up-regulated by stable expression of either constitutively active
Rheb or dominant negative AMP activated protein kinase
Yuan et al., CNS Neurosci Ther 2012 (Glioblastoma) :
Subsequently, activated
AMPK inhibited
mTOR signaling and downregulated antiapoptosis protein Bcl-2, which was contributed to the additive antiproliferation effects of combination treatment
Vadysirisack et al., Mol Cell Biol 2011 :
We show that
Redd1 loss
leads to elevated
mammalian TORC1 (mTORC1) activity, which explains the increased p53 translation and protein levels ... Together, these findings suggest that
REDD1 mediated suppression of
mTORC1 activity exerts feedback control on p53, thereby limiting the apoptotic response and contributing to cellular survival following DNA damage
Zou et al., Dev Cell 2011 :
Rheb1 is
required for
mTORC1 and myelination in postnatal brain development ... Our study demonstrates that
Rheb1 is
essential for
mTORC1 signaling and myelination in the brain, and suggests that mTORC1 signaling plays a role in selective cellular adaptations, rather than general cellular viability
Shao et al., J Hepatol 2012 (Carcinoma, Hepatocellular...) :
The inhibition of both
mTORC1/2 not only efficiently
blocked mTORC1 signaling, but also abrogated AKT-feedback activation caused by selective mTORC1 inhibition
Fonseca et al., J Biol Chem 2011 :
Our data also reveal striking diversity in the
requirements for
MEK/ERK in the control of
mTORC1 between different cell types, pointing to additional signaling connections between phorbol esters and mTORC1, which do not involve MEK/ERK
Chen et al., Dev Cell 2010 :
Activated
FoxO1 inhibits
mTORC1 by TSC2 dependent and TSC2 independent mechanisms ...
Sesn3 , in turn,
inhibits mTORC1 activity in Tsc2-proficient cells ... Thus, under stress conditions,
FoxO inhibits the anabolic activity of
mTORC1 , a major consumer of cellular energy, while activating Akt, which increases cellular energy metabolism, thereby maintaining cellular energy homeostasis
Bakan et al., Curr Opin Lipidol 2012 :
Recent studies indicate that
mTORC1 regulates
SREBP-1 activation at multiple levels
Chao et al., J Agric Food Chem 2011 (Glioblastoma) :
Activation of
AMPK induces a-mangostin mediated phosphorylation of raptor, which subsequently associates with 14-3-3? and
results in the loss of
mTORC1 activity
Ghosh et al., PloS one 2010 :
Here we investigated the potential
regulation of
mTOR signaling by
SIRT1 in response to nutrients and cellular stress ... We demonstrate that
SIRT1 deficiency
results in elevated
mTOR signaling , which is not abolished by stress conditions ... Furthermore, we demonstrate that
SIRT1 interacts with TSC2, a component of the mTOR inhibitory-complex upstream to mTORC1, and
regulates mTOR signaling in a TSC2 dependent manner
Kuraishy et al., Proc Natl Acad Sci U S A 2007 (Cell Transformation, Neoplastic) :
Here we show that the CREB coactivator
TORC2 directly
regulates TCL1 expression independent of CREB Ser-133 phosphorylation and CBP/p300 recruitment
Lu et al., Cancer Res 2010 (Skin Neoplasms) :
Small GTPase
Ras homologue enriched in brain (RHEB) binds and
activates the key metabolic regulator
mTORC1 , which has an important role in cancer cells, but the role of RHEB in cancer pathogenesis has not been shown
Blancquaert et al., Mol Endocrinol 2010 :
mTORC1 dependent
S6K1 phosphorylation in response to both insulin and cAMP required amino acids, whereas inhibition of AMP activated protein kinase and glycogen synthase kinase 3 enhanced insulin but not cAMP effects
Huang et al., Mol Cell Biol 2008 :
However, how
mTORC2 is regulated and whether the
TSC1-TSC2 complex is
involved are unknown ... Our data also suggest that the
TSC1-TSC2 complex positively
regulates mTORC2 in a manner independent of its GTPase activating protein activity toward Rheb ... These data demonstrate that the
TSC1-TSC2 complex inhibits
mTORC1 and activates mTORC2, which through different mechanisms promotes Akt activation ... These data demonstrate that the
TSC1-TSC2 complex inhibits mTORC1 and
activates mTORC2 , which through different mechanisms promotes Akt activation
McKinney et al., Genes Dev 2013 (Cytomegalovirus Infections) :
Coordinate control of PABP1, Paip2, and
EDD1 required the virus encoded UL38
mTORC1 activator and resulted in augmented Paip2 synthesis, stability, and association with PABP1 ... Coordinate control of PABP1,
Paip2 , and EDD1
required the virus encoded UL38
mTORC1 activator and resulted in augmented Paip2 synthesis, stability, and association with PABP1 ... Coordinate control of
PABP1 , Paip2, and EDD1
required the virus encoded UL38
mTORC1 activator and resulted in augmented Paip2 synthesis, stability, and association with PABP1
Foster et al., J Biol Chem 2010 (MAP Kinase Signaling System) :
These data suggest that
mTORC1 activation
leads to
raptor multisite phosphorylation and that raptor Ser ( 863 ) phosphorylation functions as a master biochemical switch that modulates hierarchical raptor phosphorylation ( e.g. on Ser ( 859 ) and Ser ( 855 ) )
Yuan et al., J Biol Chem 2012 (Insulin Resistance) :
Lrictor ( KO ) mice also manifest defects in
insulin activated
mTORC1 activity, evidenced by decreased S6 kinase and Lipin1 phosphorylation
Tan et al., Cancer Cell 2010 (Cell Transformation, Neoplastic...) :
On loss of PPP2R2B,
mTORC1 inhibitor rapamycin
triggers a compensatory
Myc phosphorylation in PDK1 dependent, but PI3K and AKT independent manner, resulting in resistance ... On loss of PPP2R2B,
mTORC1 inhibitor rapamycin
triggers a compensatory Myc phosphorylation in PDK1 dependent, but
PI3K and AKT independent manner, resulting in resistance
Guertin et al., Dev Cell 2006 :
Thus, mTORC1 function is essential in early development,
mLST8 is
required only for
mTORC2 signaling, and mTORC2 is a necessary component of the Akt-FOXO and PKCalpha pathways
Finlay et al., J Exp Med 2012 :
The present study now demonstrates that
mTORC1 activity in CD8 ( + ) T cells is not
dependent on PI3K or
Akt but is critical to sustain glucose uptake and glycolysis in CD8 ( + ) T cells ... The present study now demonstrates that
mTORC1 activity in CD8 ( + ) T cells is not
dependent on
PI3K or Akt but is critical to sustain glucose uptake and glycolysis in CD8 ( + ) T cells
Hiraoka et al., Oncogene 2011 :
A well conserved threonine in the turn motif ( TM ) is also constitutively phosphorylated by
mTORC2 and
contributes to the stability of
Akt
Mazei-Robison et al., Neuron 2011 :
Chronic morphine decreases
mTORC2 activity, and overexpression of
Rictor , a component of mTORC2,
prevents morphine induced changes in cell morphology and activity
Wang et al., J Biol Chem 2006 :
Here we demonstrate that
insulin produces a stable
increase in the kinase activity of
mTORC1 in 3T3-L1 adipocytes ... The stimulatory effects of insulin on both
4EBP1 kinase activity and binding occurred rapidly and at physiological concentrations of insulin, and both effects
required an intact
mTORC1 ... The stimulatory effects of
insulin on both 4EBP1 kinase activity and binding occurred rapidly and at physiological concentrations of insulin, and both effects
required an intact
mTORC1
Mills et al., Proc Natl Acad Sci U S A 2008 (Lymphoma) :
Here, we demonstrate that loss of
TSC2 in the E mu-myc murine lymphoma model
leads to
mTORC1 activation and accelerated oncogenesis caused by a defective apoptotic program despite compromised AKT phosphorylation
Yip et al., Mol Cell 2010 :
Extended incubation with FKBP12-rapamycin compromises the structural integrity of mTORC1 in a stepwise manner, leading us to propose a model in which rapamycin inhibits
mTORC1 mediated phosphorylation of 4E-BP1 and
S6K1 through different mechanisms ... Extended incubation with FKBP12-rapamycin compromises the structural integrity of mTORC1 in a stepwise manner, leading us to propose a model in which rapamycin inhibits
mTORC1 mediated phosphorylation of
4E-BP1 and S6K1 through different mechanisms
Weston et al., J Neurosci 2012 (Synaptic Transmission) :
We therefore performed an electrophysiological and morphological comparison of glutamatergic and GABAergic neurons in which
mTOR signaling was either
increased by loss of the repressor
Pten or decreased by treatment with rapamycin
Sviripa et al., Bioorg Med Chem Lett 2013 :
AMPK also regulates lipid synthesis by inhibiting acetyl-CoA carboxylase (ACC) and
regulates mTOR signaling by activating TSC2 ... AMPK also regulates lipid synthesis by inhibiting acetyl-CoA carboxylase (ACC) and
regulates mTOR signaling by activating
TSC2 ... AMPK also regulates lipid synthesis by inhibiting
acetyl-CoA carboxylase (ACC) and
regulates mTOR signaling by activating TSC2
Orlova et al., J Clin Invest 2010 :
STRADalpha deficiency
results in aberrant
mTORC1 signaling during corticogenesis in humans and mice ... Consistent with the observations in human PMSE brain, knockdown of STRADalpha in vivo resulted in cortical malformation, enhanced
mTORC1 activation , and abnormal nuclear localization of
LKB1
Shaw , Acta Physiol (Oxf) 2009 (Neoplasms) :
Many details of the molecular mechanism by which
AMPK inhibits
mTORC1 signalling have also been decoded in the past 5 years
Dentin et al., Nature 2007 (Diabetes Mellitus) :
Insulin disrupts
TORC2 activity by induction of the Ser/Thr kinase SIK2, which we show here undergoes AKT2 mediated phosphorylation at Ser 358 ... Activated
SIK2 in turn
stimulated the Ser 171 phosphorylation and cytoplasmic translocation of
TORC2
Hussain et al., Mol Cell Biol 2013 :
Here, we show that the ubiquitin hydrolase
UCH-L1 regulates the balance of mTOR signaling by disrupting
mTORC1
Gupta et al., Blood 2012 (Lymphoma) :
Dual
mTORC1/mTORC2 inhibition
diminishes Akt activation and induces Puma dependent apoptosis in lymphoid malignancies ... Dual
mTORC1/mTORC2 inhibition
diminishes Akt activation and induces Puma dependent apoptosis in lymphoid malignancies
Xu et al., J Biol Chem 2012 :
Recent work has implicated a role for cullin-RING E3 ubiquitin ligase 7 ( CRL7 ) in targeting
IRS1 for
mTORC1/S6K1 dependent degradation
Fumarola et al., Breast Cancer Res Treat 2013 (Breast Neoplasms) :
The key role of
AMPK dependent inhibition of
mTORC1 in sorafenib mechanisms of action was confirmed by AMPKa1 silencing, which restored mTORC1 activity conferring a significant protection from cell death
Wang et al., Mol Cell Biol 2012 (Dermatitis, Seborrheic) :
Surprisingly, however,
TORC2 does not
regulate cell growth via its best characterized target,
AKT
Dunlop et al., Cell Signal 2009 :
Finally, we show that activation of
mTORC1 by both Rheb and RhebL1 is
impaired by
FKBP38 ... Finally, we show that
activation of
mTORC1 by both
Rheb and RhebL1 is impaired by FKBP38 ... Finally, we show that
activation of
mTORC1 by both Rheb and
RhebL1 is impaired by FKBP38
Rapley et al., J Biol Chem 2011 :
We examined the mechanism and contribution of this enhancement to
insulin activation of
mTORC1 signaling in 293E and HeLa cells ... Furthermore,
Rheb overexpression in 293E
activated mTORC1 signaling completely without causing PRAS40 release
Timmerman et al., Diabetes 2010 :
This defect is associated with impaired
insulin induced vasodilation and
mTORC1 signaling
Cleveland-Donovan et al., Endocrinology 2010 (Obesity) :
The mammalian target of rapamycin
(mTOR)-Rictor complex regulates phosphorylation of
AKT-serine ( 473 ) in 3T3-L1 adipocytes, but knockdown of Rictor by lentivirus delivered short hairpin RNA in sc preadipocytes did not affect AKT-serine ( 473 ) phosphorylation by IGF-I
Lazorchak et al., Mol Cell 2010 :
We further show that Akt2 specifically mediates the
Sin1-mTORC2 dependent suppression of
il7r and rag gene expression in B cells by regulating FoxO1 phosphorylation
Magri et al., Cell stem cell 2011 (Epilepsy...) :
Notably,
mTORC1 dependent
Akt inhibition and STAT3 activation were involved in the reduced self-renewal and earlier neuronal and astroglial differentiation of mutant NSCs ... Notably,
mTORC1 dependent Akt inhibition and
STAT3 activation were involved in the reduced self-renewal and earlier neuronal and astroglial differentiation of mutant NSCs
Chen et al., J Biol Chem 2011 :
The
PI3K dependent signaling kinase complex
mTORC2 ( mammalian target of rapamycin complex 2 ) has been defined as the regulatory Ser-473 kinase of Akt
Wang et al., Circ Res 2007 (Coronary Artery Disease...) :
We found that IFN-gamma mediated vascular smooth muscle cell proliferation and intimal expansion were associated with phosphorylation of the mTORC1 effector ribosomal protein S6 kinase 1, that the graft morphological changes and S6 kinase 1 activation were inhibited by the mTORC1 inhibitor rapamycin in vivo, and that
IFN-gamma induced
mTORC1 signaling was dependent on phosphatidylinositol 3-kinase activity under serum-free conditions in vitro
Masri et al., Cancer Res 2007 (Brain Neoplasms...) :
mTORC2 has recently been shown to phosphorylate and
activate Akt
Yang et al., Proc Natl Acad Sci U S A 2006 :
We also observed that
Rheb does not
activate TORC2 in human embryonic kidney 293 cells, although it potently stimulates TORC1
Park et al., Haematologica 2010 (Leukemia, Myeloid, Acute) :
However, as
mTORC1 activation is independent of PI3K/AKT in acute myeloid leukemia, dual PI3K and
mTOR inhibitors may
induce apoptosis in blast cells ... However, as
mTORC1 activation is independent of PI3K/AKT in acute myeloid leukemia, dual
PI3K and mTOR inhibitors may
induce apoptosis in blast cells ... However, as
mTORC1 activation is
independent of
PI3K/AKT in acute myeloid leukemia, dual PI3K and mTOR inhibitors may induce apoptosis in blast cells
Tan et al., PloS one 2013 :
In this study, we discovered that
mTORC1 regulates
REDD1 protein stability in a 26S proteasome dependent manner ... Inhibition of
mTORC1 resulted in reduced REDD1 protein stability and a consequent decrease in
REDD1 expression
Fetalvero et al., Mol Cell Biol 2013 (Myopathies, Structural, Congenital) :
These results suggest that aberrant
mTORC1 signaling and impaired autophagy are
consequences of the loss of
Mtm1 and may play a primary role in disease pathogenesis
Gundermann et al., J Appl Physiol 2012 (Hyperemia) :
BFR exercise
increased the phosphorylation of mTOR, S6 kinase 1,
ribosomal protein S6 , ERK1/2, and Mnk1 interacting kinase 1 ( P < 0.05 ) with no changes in
mTORC1 signaling in the SNP trial ( P > 0.05 ) ... BFR exercise
increased the phosphorylation of mTOR, S6 kinase 1, ribosomal protein S6,
ERK1/2 , and Mnk1 interacting kinase 1 ( P < 0.05 ) with no changes in
mTORC1 signaling in the SNP trial ( P > 0.05 ) ... BFR exercise
increased the phosphorylation of
mTOR , S6 kinase 1, ribosomal protein S6, ERK1/2, and Mnk1 interacting kinase 1 ( P < 0.05 ) with no changes in
mTORC1 signaling in the SNP trial ( P > 0.05 ) ... BFR exercise
increased the phosphorylation of mTOR, S6 kinase 1, ribosomal protein S6,
ERK1/2 , and Mnk1 interacting kinase 1 ( P < 0.05 ) with no changes in
mTORC1 signaling in the SNP trial ( P > 0.05 )
Wolff et al., Mol Cell Biol 2011 (Anoxia) :
Cell-type dependent
regulation of
mTORC1 by
REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia ... We previously reported that
mTORC1 regulation by hypoxia
involves Redd1 and the
Tsc1/Tsc2 complex ... We previously reported that
mTORC1 regulation by hypoxia
involves Redd1 and the Tsc1/Tsc2 complex ... AMPK activation ( using 5-aminoimidazole-4-carboxamide riboside [ AICAR ] ) induces
raptor phosphorylation and
inhibits mTORC1 in both mouse embryo fibroblasts ( MEFs ) and hepatocytes, but whereas mTORC1 inhibition is Tsc1/Tsc2 dependent in MEFs, it is independent in hepatocytes ...
AMPK activation ( using 5-aminoimidazole-4-carboxamide riboside [ AICAR ] ) induces raptor phosphorylation and
inhibits mTORC1 in both mouse embryo fibroblasts ( MEFs ) and hepatocytes, but whereas mTORC1 inhibition is Tsc1/Tsc2 dependent in MEFs, it is independent in hepatocytes
Wu et al., Am J Pathol 2013 (Cardiomegaly...) :
Cardiomyocyte apoptosis was reduced and mTORC1 activity was suppressed in cardiomyocyte Rheb1-deletion mice, suggesting that
Rheb1 regulates
mTORC1 activation in myocardium ... This study indicates that
Rheb1 is
essential for
mTORC1 activation in cardiomyocytes and suggests that targeting Rheb1-mTORC1 signaling, such as by As-IV treatment, may be an effective therapeutic method for treating patients with adverse cardiac remodeling after MI and hypertrophy
Chou et al., PloS one 2012 :
Indeed
mTORC1 inhibitor rapamycin
prevented HSF1-S326 phosphorylation, suggesting that this complex is involved in HSF1 regulation in stress
Flinn et al., Mol Biol Cell 2010 :
These data suggest that integrity of late endosomes is essential for amino acid- and
insulin stimulated
mTORC1 signaling and that blocking the early/late endosomal conversion prevents mTOR from interacting with Rheb in the late endosomal compartment
Balasubramanian et al., Cardiovasc Hematol Agents Med Chem 2009 (Cardiomegaly) :
mTORC2 regulates the actin cytoskeleton in addition to activating
Akt ( Protein kinase B ) for the subsequent removal of proapoptotic factors via the UPS for cell survival
Xu et al., J Biol Chem 2012 :
Cycloheximide, a translation elongation inhibitor known to augment intracellular amino acid levels, prevented the effect of bafilomycin on amino acids levels and completely reversed its inhibition of
EGF induced
mTORC1 activation
Chang et al., Eur J Immunol 2012 :
Sin1 deficiency blocks the
mTORC2 dependent
Akt phosphorylation in T cells during development and activation
Akcakanat et al., Biochem Biophys Res Commun 2007 :
mTORC1 is rapamycin-sensitive, and
results in phosphorylation of 4E-BP1 and
S6K1 ...
mTORC1 is rapamycin-sensitive, and
results in phosphorylation of
4E-BP1 and S6K1
Gwinn et al., Mol Cell 2008 :
AMPK phosphorylation of the TSC2 tumor suppressor
contributes to suppression of
mTORC1 ; however, TSC2-deficient cells remain responsive to energy stress ... The phosphorylation of
raptor by AMPK is
required for the inhibition of
mTORC1 and cell-cycle arrest induced by energy stress
Ju et al., Cell Signal 2013 :
We have previously demonstrated that
syndecan 4 (S4) regulates the intracellular localization of
mTORC2 , thus altering phosphorylation of Akt at serine473 ( Ser473 ), one of two critical phosphorylation sites essential for the full activation of Akt [1 ]
Marzec et al., Blood 2008 (Lymphoma, T-Cell, Cutaneous) :
The
mTORC1 , PI3K/Akt, and MEK/ERK pathways could also be
activated by
IL-2 in the primary leukemic, mitogen preactivated CTCL cells
Hietakangas et al., Genes Dev 2007 :
Here we analyze the role of
TORC2 mediated
AKT phosphorylation in Drosophila
Jaafar et al., Cell communication and signaling : CCS 2013 (Muscular Atrophy) :
These observations suggest that
PLD1 acts through the activation of both
mTORC1 and mTORC2 to induce positive trophic effects on muscle cells ... These observations suggest that
PLD1 acts through the activation of both mTORC1 and
mTORC2 to induce positive trophic effects on muscle cells
Kuehn et al., J Biol Chem 2011 :
In mouse bone marrow derived mast cells, PGE ( 2 ) was found to induce activation of mTORC1 ( mTOR complexed to raptor ) as indicated by increased p70S6K and
4E-BP1 phosphorylation, and
activation of
mTORC2 ( mTOR complexed to rictor ), as indicated by increased phosphorylation of AKT at position Ser ( 473 ) ... In mouse bone marrow derived mast cells, PGE ( 2 ) was found to induce activation of mTORC1 ( mTOR complexed to raptor ) as indicated by increased
p70S6K and 4E-BP1 phosphorylation, and
activation of
mTORC2 ( mTOR complexed to rictor ), as indicated by increased phosphorylation of AKT at position Ser ( 473 )
Kwan et al., PloS one 2013 (Uterine Cervical Neoplasms) :
Besides, impaired
mTOR signaling activity also
reduced DVL3 expression
Guo et al., Arterioscler Thromb Vasc Biol 2011 :
According to Western blot analysis and immunoprecipitation results, rHDL promoted mTOR phosphorylation, mTOR-rictor complex formation, and
mTOR-rictor dependent
Akt activation, which were accompanied by increased nuclear translocation of human telomerase reverse transcriptase and enhanced nuclear telomerase activity ... According to Western blot analysis and immunoprecipitation results, rHDL promoted
mTOR phosphorylation, mTOR-rictor complex formation, and
mTOR-rictor dependent Akt
activation , which were accompanied by increased nuclear translocation of human telomerase reverse transcriptase and enhanced nuclear telomerase activity
Zhou et al., Cell Res 2013 :
Third, we examined the involvement of transcription factor EB (TFEB) and demonstrated that
TFEB activation following
mTORC1 suppression is necessary but not sufficient for lysosomal activation
Lam et al., PLoS Pathog 2012 (Tuberculosis) :
We identify the human quinone oxidoreductase NQO1 as a nitazoxanide target and propose, based on experiments with cells expressing NQO1 or not, that
NQO1 inhibition is partly
responsible for
mTORC1 inhibition and enhanced autophagy
Joha et al., Oncogene 2012 (Leukemia, Myelogenous, Chronic, BCR-ABL Positive) :
Our findings provide new mechanistic insights into the
role of
mTORC2 in
BCR-ABL ( + ) cells and indicate that regulation by GILZ may influence TKI sensitivity ... Our findings provide new mechanistic insights into the
role of
mTORC2 in
BCR-ABL ( + ) cells and indicate that regulation by GILZ may influence TKI sensitivity
Falcon et al., Cancer Res 2011 (Neoplasms, Experimental...) :
In this study, we examined the
effects of
mTORC1/2 dual inhibition on
VEGF production, tumor angiogenesis, vascular regression, and vascular regrowth, and we compared the effects of dual inhibition to mTORC1 inhibition alone
Wu et al., J Biol Chem 2012 :
Although expression of the Raptor T908A mutant did not affect the mTORC1 integrity, it markedly impaired the
mTORC1 activation by insulin or by overexpression of the small
GTP binding protein RheB under nutrient starvation ... Although expression of the Raptor T908A mutant did not affect the mTORC1 integrity, it markedly impaired the
mTORC1 activation by
insulin or by overexpression of the small GTP binding protein RheB under nutrient starvation ... Our findings demonstrate an important
role for
ICK in modulating the activity of
mTORC1 through phosphorylation of Raptor Thr-908 and thus implicate a potential signaling mechanism by which ICK regulates cell proliferation and division
Koike-Kumagai et al., EMBO J 2009 :
Moreover,
TORC2 is
essential for
Trc phosphorylation on a residue that is critical for Trc activity in vivo and in vitro
Nölting et al., J Mol Endocrinol 2012 :
Lovastatin alone significantly reduced MPC and MTT cell viability at therapeutically relevant doses and
inhibited both
ERK and AKT signalling, but increased
mTORC1/p70S6K signalling ... Lovastatin alone significantly reduced MPC and MTT cell viability at therapeutically relevant doses and
inhibited both ERK and
AKT signalling, but increased
mTORC1/p70S6K signalling
Dennis et al., J Biol Chem 2013 :
These findings were extended to a cell culture system wherein loss of 4E-BP1 and 4E-BP2 resulted in elevated interaction of p70S6K1 with
IGF1 induced activation of
mTORC1 in conjunction with an enhanced rate of p70S6K1 phosphorylation at Thr-389 ... Together, these findings support the conclusion that, in the absence of 4E-BP proteins,
mTORC1 mediated phosphorylation of
p70S6K1 is elevated by a reduction in competition between the two substrates for interaction with raptor ... Together, these findings support the conclusion that, in the absence of 4E-BP proteins,
mTORC1 mediated phosphorylation of
p70S6K1 is elevated by a reduction in competition between the two substrates for interaction with raptor
Shimamura et al., Cancer Res 2008 (Adenocarcinoma...) :
In contrast,
Hsp90 inhibition overcomes these limitations in vitro and depletes cells of EGFR, other RTKs, and phospho-Akt and
inhibits mTOR signaling whether or not T790M is present
Dickson , J Lipid Res 2008 (Inflammation) :
Advances in understanding how the de novo synthesis of ceramide and complex sphingolipids is regulated have been made, and they demonstrate that the
Target Of Rapamycin Complex 2 (TORC2) controls
ceramide synthase activity ... The activity of
Slm1 and Slm2 has also been shown to be
regulated during heat stress by phosphoinositides and
TORC2 , along with sphingoid long-chain bases and the Pkh1 and Pkh2 protein kinases, to control the actin cytoskeleton, the trafficking of nutrient transporters, and cell viability ... The activity of Slm1 and
Slm2 has also been shown to be
regulated during heat stress by phosphoinositides and
TORC2 , along with sphingoid long-chain bases and the Pkh1 and Pkh2 protein kinases, to control the actin cytoskeleton, the trafficking of nutrient transporters, and cell viability
Amelio et al., Proc Natl Acad Sci U S A 2007 :
Furthermore,
TORC2 and NONO complex on cAMP-responsive promoters, and
NONO acts as a bridge between the CREB/TORC complex and RNA polymerase II
Santini et al., J Biol Chem 2012 (MAP Kinase Signaling System...) :
These studies demonstrate that, in D1R expressing MSNs, l-DOPA induced activation of ERK and
mTORC1 requires
DARPP-32 and indicates the importance of the cAMP/DARPP-32 signaling cascade in dyskinesia
Bonito-Oliva et al., Neuropharmacology 2013 :
Haloperidol promotes
mTORC1 dependent phosphorylation of
ribosomal protein S6 via dopamine- and cAMP regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1
Moore et al., J Biol Chem 2011 (MAP Kinase Signaling System) :
In this study, we investigated the
role of the mammalian target of rapamycin complex (
mTORC)-2 in
Akt regulation using the recently identified small molecule ATP competitive mTOR inhibitors PP242 and Torin1
Yoon et al., J Cell Biol 2011 :
Furthermore, amino acids stimulate PLD1 translocation to the lysosomal region where
mTORC1 activation occurs in an
hVps34 dependent manner, and this translocation is necessary for mTORC1 activation
Zhang et al., Proc Natl Acad Sci U S A 2012 :
Taken together, these data reveal a signaling pathway by which phosphatidic acid synthesized via the glycerol-3-phosphate pathway
inhibits mTORC2 activity by decreasing the association of rictor and
mTOR , thereby down regulating insulin action
Dormond-Meuwly et al., Biochem Biophys Res Commun 2011 (Neoplasms...) :
Downregulation of mTORC1 but not mTORC2 had similar effects showing that the inhibition of
mTORC1 is
responsible for the activation of
MAPK ... Taken together these results show that blocking
mTORC1 in endothelial cells
activates MAPK and that a combined inhibition of MAPK and mTOR has additive anti-angiogenic effects
Woo et al., J Biol Chem 2007 (Breast Neoplasms...) :
Despite no significant effect of PRR5 on
mTORC2 mediated
Akt phosphorylation, PRR5 silencing inhibits Akt and S6K1 phosphorylation and reduces cell proliferation rates, a result consistent with PRR5 roles in cell growth and tumorigenesis
Sancak et al., Science 2008 :
Conversely, expression of a guanosine diphosphate bound
Rag mutant
prevented stimulation of
mTORC1 by amino acids
Glidden et al., J Biol Chem 2012 :
Although
Rictor is
required for the stability and activity of
mTORC2 , little is known about functional regions or post-translational modifications within Rictor that are responsible for regulating mTORC2 ... p300 mediated acetylation of Rictor increases mTORC2 activity toward Akt, whereas site directed mutants within the acetylation region of Rictor exhibit reduced
insulin-like growth factor 1 (IGF-1) stimulated
mTORC2 kinase activity
Razmara et al., Cell communication and signaling : CCS 2013 :
Inhibition of
phosphatidylinositol 3-kinase (PI3K) inhibited PDGF-BB activation of both
mTORC1 and mTORC2 ... Inhibition of
phosphatidylinositol 3-kinase (PI3K) inhibited PDGF-BB activation of both mTORC1 and
mTORC2 ... Inhibition of phosphatidylinositol 3-kinase (PI3K) inhibited
PDGF-BB activation of both
mTORC1 and mTORC2 ... Inhibition of phosphatidylinositol 3-kinase (PI3K) inhibited
PDGF-BB activation of both mTORC1 and
mTORC2 ... In addition, PDGF-BB induced activation of
mTORC1 , as measured by phosphorylation of the downstream S6 protein, was
dependent on
phospholipase D ( PLD ) ... In addition,
PDGF-BB induced activation of
mTORC1 , as measured by phosphorylation of the downstream S6 protein, was dependent on phospholipase D ( PLD ) ... Thus, whereas both mTORC1 and
mTORC2 are activated in a
PI3K dependent manner, different additional signaling pathways are needed ... Thus, whereas both
mTORC1 and mTORC2 are activated in a
PI3K dependent manner, different additional signaling pathways are needed ... mTORC1 is activated in a PLD dependent manner and promotes phosphorylation of the S6 protein, whereas
mTORC2 , in concert with PLC? signaling,
promotes Akt phosphorylation ...
mTORC1 is activated in a
PLD dependent manner and promotes phosphorylation of the S6 protein, whereas mTORC2, in concert with PLC? signaling, promotes Akt phosphorylation
Sarkar et al., Mol Cell 2011 (Huntington Disease) :
Additionally, NO inhibits IKKß and reduces AMPK phosphorylation, leading to
mTORC1 activation via
TSC2
Zhang et al., J Biol Chem 2010 (Glioblastoma) :
Activation of AMP activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via
p53 activation and
mTORC1 inhibition ... Our study suggests that activation of AMPK by TMZ contributes to glioblastoma cell apoptosis, probably by promoting
p53 activation and
inhibiting mTORC1 signaling
Pulakat et al., Am J Physiol Regul Integr Comp Physiol 2011 (Cardiovascular Diseases...) :
We propose a scenario, whereby
mTORC1-signaling mediated increase in
AT2R expression in the INS-resistant ZO heart is a cardioprotective adaptation to overnutrition
Babcock et al., J Biol Chem 2013 :
Although bortezomib induces eukaryotic initiating factor 2a phosphorylation,
mTORC1 activity was also
required for downstream induction of the UPR transcription factors ATF4 and
CHOP by a mechanism involving increased expression of c-MYC ... Although bortezomib induces eukaryotic initiating factor 2a phosphorylation,
mTORC1 activity was also
required for downstream induction of the UPR transcription factors
ATF4 and CHOP by a mechanism involving increased expression of c-MYC ... These findings indicate that the induction of ATF4/CHOP expression occurs via
mTORC1 regulation of
c-MYC and that this signaling pathway is a major determinant in the ability of bortezomib to induce apoptosis
Pracheil et al., J Biol Chem 2013 :
It has been reported that protein
phosphatase 2A (PP2A) and the Far3-7-8-9-10-11 complex ( Far complex ) negatively
regulate TORC2 signaling in yeast
Bozulic et al., Curr Opin Cell Biol 2009 (Neoplasms) :
This present review concerns
PKB regulation by
mTORC2 and DNA-PK in a stimulus dependent and context dependent manner and the possible implications of this for PKB activity, substrate specificity and therapeutic intervention
Carracedo et al., J Clin Invest 2008 (MAP Kinase Signaling System...) :
Inhibition of
mTORC1 leads to
MAPK pathway activation through a PI3K dependent feedback loop in human cancer ... Taken together, our findings identify
MAPK activation as a
consequence of
mTORC1 inhibition and underscore the potential of a combined therapeutic approach with mTORC1 and MAPK inhibitors, currently employed as single agents in the clinic, for the treatment of human cancers
Tanaka et al., Clin Cancer Res 2011 (Neoplasms) :
Effects on
Akt phosphorylation
induced by
mTORC1 inhibition were tested with CH5132799 and compared with mTORC1 and PI3K/mTOR inhibitors
Montero et al., Mol Cancer Ther 2012 (Ovarian Neoplasms) :
Therefore,
mTORC1 probably
controls p4E-BP1 along two distinct pathways, one of them sensitive to rapamycin and another insensitive
Chen et al., Mol Carcinog 2010 (Neoplasms) :
In this report, we focused on studying the
role of mTORC1 and
mTORC2 in rapamycin mediated Akt and
ERK phosphorylation, and the antitumor effect of rapamycin in cancer cells in combination with Akt and ERK inhibitors ... In this report, we focused on studying the
role of
mTORC1 and mTORC2 in rapamycin mediated Akt and
ERK phosphorylation, and the antitumor effect of rapamycin in cancer cells in combination with Akt and ERK inhibitors ... In this report, we focused on studying the
role of mTORC1 and
mTORC2 in rapamycin mediated
Akt and ERK phosphorylation, and the antitumor effect of rapamycin in cancer cells in combination with Akt and ERK inhibitors ... In this report, we focused on studying the
role of
mTORC1 and mTORC2 in rapamycin mediated
Akt and ERK phosphorylation, and the antitumor effect of rapamycin in cancer cells in combination with Akt and ERK inhibitors ... Collectively, we conclude that
mTORC2 plays a much more important role than mTORC1 in rapamycin mediated phosphorylation of Akt and
ERK , and cotargeting AKT and ERK signaling may be a new strategy for enhancing the efficacy of rapamycin based therapeutic approaches in cancer cells ... Collectively, we conclude that
mTORC2 plays a much more important role than mTORC1 in rapamycin mediated phosphorylation of
Akt and ERK, and cotargeting AKT and ERK signaling may be a new strategy for enhancing the efficacy of rapamycin based therapeutic approaches in cancer cells
Li et al., J Biol Chem 2010 :
In mammalian cells, uncontrolled activation of Rab5 and
Arf1 strongly
inhibit mTORC1 activity ... In mammalian cells, uncontrolled activation of
Rab5 and Arf1 strongly
inhibit mTORC1 activity ... Interestingly, the effect of Rab5 and Arf1 on mTORC1 is specific to amino acid stimulation, whereas glucose induced
mTORC1 activation is not
blocked by Rab5 or
Arf1 ... Interestingly, the effect of Rab5 and Arf1 on mTORC1 is specific to amino acid stimulation, whereas glucose induced
mTORC1 activation is not
blocked by
Rab5 or Arf1 ... Similarly, active Rab5 selectively inhibits
mTORC1 activation by Rag GTPases, which are involved in amino acid signaling, but does not
inhibit the effect of
Rheb , which directly binds and activates mTORC1 ... Similarly, active
Rab5 selectively
inhibits mTORC1 activation by Rag GTPases, which are involved in amino acid signaling, but does not inhibit the effect of Rheb, which directly binds and activates mTORC1
Wang et al., Diabetes 2013 (Diabetes Mellitus) :
Further, inhibition of
miR-7a activates
mTOR signaling and promotes adult ß-cell replication in mouse primary islets, which can be reversed by the treatment with a well-known mTOR inhibitor, rapamycin
Jung et al., Mol Biol Cell 2009 :
ULK-Atg13-FIP200 complexes
mediate mTOR signaling to the autophagy machinery ...
ULK-Atg13-FIP200 complexes
mediate mTOR signaling to the autophagy machinery ...
ULK-Atg13-FIP200 complexes
mediate mTOR signaling to the autophagy machinery ... These findings demonstrate that the
ULK-Atg13-FIP200 complexes are direct targets of mTOR and important regulators of autophagy in
response to
mTOR signaling ... These findings demonstrate that the
ULK-Atg13-FIP200 complexes are direct targets of mTOR and important regulators of autophagy in
response to
mTOR signaling ... These findings demonstrate that the
ULK-Atg13-FIP200 complexes are direct targets of mTOR and important regulators of autophagy in
response to
mTOR signaling
Dunaway et al., Mol Cell Biol 2011 :
Slit2 stimulates angiogenesis through
mTORC2 dependent activation of
Akt and Rac GTPase, the activities of which are inhibited in the presence of ephrin-A1 ... Slit2 stimulates angiogenesis through
mTORC2 dependent
activation of Akt and
Rac GTPase, the activities of which are inhibited in the presence of ephrin-A1
Jiang et al., Am J Pathol 2008 (Angiomyolipoma...) :
Together, these data show that
mTORC1 activity is insufficient for increased glycolysis in tumors and that constitutive
mTOR activity negatively
regulates glucose transporter trafficking
Roux et al., Proc Natl Acad Sci U S A 2004 (MAP Kinase Signaling System...) :
Phosphatidylinositol 3-kinase (PI3K) inactivates the tumor suppressor complex and
enhances mTOR signaling by means of phosphorylation of tuberin by Akt
Wong et al., J Biol Chem 2010 :
Inhibition of AMPK prevented translation repression by cordycepin and abolished 4EBP1 dephosphorylation, indicating that the effect of cordycepin on
mTOR signaling and protein synthesis is
mediated by
AMPK activation
James et al., Mol Cell Biol 2009 (Meningioma...) :
Merlin does not regulate
mTORC1 via the established mechanism of phosphoinositide 3-kinase-Akt or
mitogen activated protein kinase/extracellular signal
regulated kinase mediated TSC2 inactivation and may instead regulate TSC/mTOR signaling in a novel fashion ...
Merlin does not
regulate mTORC1 via the established mechanism of phosphoinositide 3-kinase-Akt or mitogen activated protein kinase/extracellular signal regulated kinase mediated TSC2 inactivation and may instead regulate TSC/mTOR signaling in a novel fashion
Balgi et al., PloS one 2009 :
TSC2 , a negative regulator of mTORC1, was
required for inhibition of
mTORC1 signaling by rottlerin but not for mTORC1 inhibition by perhexiline, niclosamide and amiodarone ... Transient exposure of immortalized mouse embryo fibroblasts to these drugs was not toxic in nutrient-rich conditions but led to rapid cell death by apoptosis in starvation conditions, by a mechanism determined in large part by the tuberous sclerosis complex protein
TSC2 , an upstream
regulator of
mTORC1
López-Lago et al., Mol Cell Biol 2009 (Mesothelioma) :
Loss of the tumor suppressor gene
NF2 , encoding merlin, constitutively
activates integrin dependent
mTORC1 signaling
Jung et al., J Toxicol Sci 2012 :
In conclusion, OA increases the proliferation and decreases the starvation induced apoptosis of SK-Hep1 cells via
mTORC1 activation
mediated by negative regulation of
AMPK
Wang et al., PloS one 2013 :
Western blotting showed that the PP242 inhibition of
mTORC2 mediated
AKT phosphorylation at Ser 473 ( AKT ( S473 ) ) was transient only in the first few hours of the PP242 treatment ... The parallel increase of AKT ( S473 ) and EGFR ( T1068 ) in the cells following PP242 treatment raised the possibility that
EGFR phosphorylation might
contribute to the PP242 incomplete inhibition of
mTORC2
Winter et al., Am J Physiol Cell Physiol 2011 :
Previous studies have shown that, in part, Akt and
ERK promote
mTORC1 signaling through phosphorylation of a GTPase activator protein (GAP), referred to as tuberous sclerosis complex 2 (TSC2), that acts as an upstream inhibitor of mTORC1 ... Previous studies have shown that, in part,
Akt and ERK
promote mTORC1 signaling through phosphorylation of a GTPase activator protein (GAP), referred to as tuberous sclerosis complex 2 (TSC2), that acts as an upstream inhibitor of mTORC1
Haas et al., Cell Metab 2012 (Diabetes Mellitus, Type 2...) :
Liver insulin receptor knockout ( LIRKO ) mice show that in the physiological context of feeding, hepatic
insulin signaling is not
required for the induction of
mTORC1 , an upstream activator of the lipogenic regulator, SREBP-1c
Alexander et al., Cell cycle (Georgetown, Tex.) 2010 :
We found that
TSC2 activation
results in
mTORC1 repression and subsequent induction of autophagy
Magnuson et al., Biochem J 2012 :
mTORC1 ( mammalian TORC1 ) phosphorylates and
activates S6K1 and S6K2, whose first identified substrate was rpS6 ( ribosomal protein S6 ), a component of the 40S ribosome ...
mTORC1 ( mammalian TORC1 ) phosphorylates and
activates S6K1 and
S6K2 , whose first identified substrate was rpS6 ( ribosomal protein S6 ), a component of the 40S ribosome
Gulhati et al., Cancer Res 2011 (Colorectal Neoplasms...) :
mTORC1 and
mTORC2 regulate
EMT , motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways ...
mTORC1 and mTORC2
regulate EMT , motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways
Ryu et al., Cell Metab 2009 (Glucose Intolerance...) :
TORC2 regulates hepatic
insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1
Werzowa et al., Br J Dermatol 2009 (Melanoma...) :
Inhibition of
mTORC2 led to reduced levels of phosphorylated
AKT
Hayashi et al., Am J Physiol Endocrinol Metab 2007 :
Consistent with this, GH increased the phosphorylation of
TSC2 , an upstream
regulator of
mTORC1 , at sites that are targets for Akt/PKB
Tzatsos , J Biol Chem 2009 :
Overall, these data provide new insights in the molecular mechanisms by which
mTORC1 inhibits PI
3-kinase/Akt signaling at the level of IRS-1 and suggest that mTOR signaling toward Akt is scaffold dependent ... Overall, these data provide new insights in the molecular mechanisms by which
mTORC1 inhibits
PI 3-kinase/Akt signaling at the level of IRS-1 and suggest that mTOR signaling toward Akt is scaffold dependent
Maehama et al., J Biol Chem 2008 :
In addition, RalA knockdown suppressed Rheb induced S6 kinase phosphorylation, and the constitutively active form of
RalA induced
mTORC1 activation in the absence of Rheb
Arous et al., Diabetologia 2011 :
Oleate mediated
mTORC1 activation
required phospholipase D activation, which produces phosphatidic acid and is known to render mTORC1 rapamycin resistant
Nishioka et al., Int J Cancer 2009 (Leukemia, Myeloid, Acute) :
ATRA ( 0.1-1 microM ) upregulated levels of
RTP801 , a negative regulator of mTORC1, and
inhibited mTORC1 signaling as assessed by measurement of the levels of p-p70S6K and p-4E-BP1 in HL60 and NB4 cells
McGhee et al., J Nutr 2009 (Diabetes Mellitus, Experimental...) :
Overall, the results demonstrate that changes in
REDD1 expression likely
contribute to the regulation of
mTORC1 signaling during food deprivation and refeeding
Melnik , J Obes 2012 :
Leucine thus functions as a maternal-neonatal relay for
mTORC1 dependent neonatal ß-cell proliferation and
insulin secretion
Li et al., J Ethnopharmacol 2012 (Arthritis, Experimental) :
To investigate the role of
PI3K/Akt/mTOR signaling mediated by
BAFF/BAFF-R in antibodies production and the regulation of Pae on the signaling pathway in rats with collagen induced arthritis ( CIA ) ... To investigate the role of
PI3K/Akt/mTOR signaling mediated by
BAFF/BAFF-R in antibodies production and the regulation of Pae on the signaling pathway in rats with collagen induced arthritis ( CIA ) ...
PI3K/Akt/mTOR signaling mediated by
BAFF/BAFF-R participates in antibodies production by B lymphocytes of CIA rats ...
PI3K/Akt/mTOR signaling mediated by
BAFF/BAFF-R participates in antibodies production by B lymphocytes of CIA rats
Sancak et al., Mol Cell 2007 :
Insulin stimulates Akt/PKB mediated phosphorylation of PRAS40, which prevents its inhibition of
mTORC1 in cells and in vitro
Durán et al., Mol Cell 2012 :
Inhibition of glutaminolysis prevented GTP loading of
RagB and lysosomal translocation and subsequent
activation of
mTORC1 ... Constitutively active
Rag heterodimer
activated mTORC1 in the absence of glutaminolysis ... Thus,
mTORC1 senses and is
activated by
glutamine and leucine via glutaminolysis and a-ketoglutarate production upstream of Rag
Gibbons et al., Semin Oncol 2009 (Neoplasms) :
Activated mTORC1 regulates protein synthesis by directly phosphorylating
4E-binding protein 1 (4E-BP1) and p70S6K ( S6K ), translation initiation factors that are important to cap dependent mRNA translation, which increases the level of many proteins that are needed for cell cycle progression, proliferation, angiogenesis, and survival pathways ...
Activated mTORC1 regulates protein synthesis by directly phosphorylating 4E-binding protein 1 (4E-BP1) and
p70S6K ( S6K ), translation initiation factors that are important to cap dependent mRNA translation, which increases the level of many proteins that are needed for cell cycle progression, proliferation, angiogenesis, and survival pathways
Wang et al., Lipids in health and disease 2012 (Obesity) :
HDL and
apoA-I could
activate PI3K-Akt-mTORC1 signaling which negatively regulates autophagy
Gan et al., Cancer Cell 2010 (Carcinoma, Renal Cell...) :
mTORC1 is a validated therapeutic
target for
renal cell carcinoma (RCC)
Wander et al., J Clin Invest 2011 (Neoplasms) :
While hypoxia, nutrient deprivation, and DNA damage restrain
mTORC1 activity, multiple genetic events constitutively
activate mTOR in cancers
Kucejova et al., Mol Cancer Res 2011 (Carcinoma, Renal Cell) :
REDD1 is upregulated by
hypoxia-inducible factor (HIF)-1 , and forced REDD1 expression is
sufficient to inhibit
mTORC1 ... REDD1 is upregulated by hypoxia-inducible factor (HIF)-1, and forced
REDD1 expression is
sufficient to inhibit
mTORC1 ...
REDD1 induced
mTORC1 inhibition is dependent on a protein complex formed by the tuberous sclerosis complex (TSC)1 and 2 ( TSC2 ) proteins ... In clear-cell renal cell carcinoma ( ccRCC ), the von Hippel-Lindau (VHL) gene is frequently inactivated leading to constitutive activation of HIF-2 and/or HIF-1, which may be expected to upregulate
REDD1 and
inhibit mTORC1 ... Understanding how ccRCCs become refractory to
REDD1 induced
mTORC1 inhibition should shed light into the development of ccRCC and may aid in patient selection for molecular targeted therapies
Bahl et al., Molecular autism 2013 :
Pam, an E3 ubiquitin ligase, binds to TSC proteins and
regulates mTORC1 signaling in the CNS, and the
FBXO45-Pam ubiquitin ligase complex plays an essential role in neurodevelopment by regulating synapse formation and growth ...
Pam , an E3 ubiquitin ligase, binds to TSC proteins and
regulates mTORC1 signaling in the CNS, and the FBXO45-Pam ubiquitin ligase complex plays an essential role in neurodevelopment by regulating synapse formation and growth
Wang et al., Science signaling 2009 (Cardiovascular Diseases...) :
Rapamycin treatment of diet induced obese mice or of transgenic mice with long-term activation of endothelial
Akt inhibits
activation of mammalian target of rapamycin
(mTOR)-rictor complex 2 and Akt, prevents vascular senescence without altering body weight, and reduces the severity of limb necrosis and ischemic stroke
Avruch et al., Am J Physiol Endocrinol Metab 2009 :
Insulin , growth factors, and a variety of cellular stressors
regulate mTORC1 by controlling Rheb GTP charging through modulating the activity of the tuberous sclerosis complex, the Rheb GTPase activating protein ... In contrast, amino acids, especially leucine,
regulate mTORC1 by controlling the ability of Rheb-GTP to activate
mTORC1 ... The rag heterodimer interacts directly with mTORC1 and may direct mTORC1 to the Rheb containing vesicular compartment in response to amino acid sufficiency, enabling
Rheb-GTP activation of
mTORC1
Kim et al., Mol Cell 2012 :
Here, we found that
mTORC2 can also
regulate insulin signaling at the level of insulin receptor substrate-1 (IRS-1) ... Our findings reveal that in addition to persistent mTORC1 signaling, heightened mTORC2 signals can promote insulin resistance due to
mTORC2 mediated degradation of
IRS-1
Matsui et al., EMBO Rep 2013 :
Rab12 regulates
mTORC1 activity and autophagy through controlling the degradation of amino-acid transporter PAT4 ... Knockdown of
Rab12 results in inhibition of autophagy and in increased activity of
mTORC1 ( mammalian/mechanistic target of rapamycin complex 1 ), an upstream regulator of autophagy
Misra et al., J Cell Biochem 2012 (Prostatic Neoplasms) :
We measured
mTORC2 dependent
Akt phosphorylation at S473 in immunoprecipitates of mTOR or Rictor from 1-LN cells ... These studies represent the first report that Epac1 mediates
mTORC2 dependent phosphorylation of
Akt ( S473 ) ... We further demonstrate that in 8-CPT-2Me-cAMP treated cells, Epac1 co-immunoprecipitates with AKAP, Raptor, Rictor, PDE3B, and PDE4D suggesting thereby that during
Epac1 induced activation of
mTORC1 and mTORC2, Epac1 may have an additional function as a `` scaffold '' protein ... We further demonstrate that in 8-CPT-2Me-cAMP treated cells, Epac1 co-immunoprecipitates with AKAP, Raptor, Rictor, PDE3B, and PDE4D suggesting thereby that during
Epac1 induced
activation of mTORC1 and
mTORC2 , Epac1 may have an additional function as a `` scaffold '' protein
Ramírez-Valle et al., Mol Cell Biol 2010 :
Mitotic
raptor promotes
mTORC1 activity, G ( 2 ) /M cell cycle progression, and internal ribosome entry site mediated mRNA translation
Jung et al., J Nutr Biochem 2013 :
The results suggested that fisetin treatment inhibits
mTORC1 activity in an
Akt dependent manner
Harston et al., Am J Physiol Heart Circ Physiol 2011 (Hypertrophy) :
Another molecular keystone involved in the hypertrophic growth process is the mammalian target of rapamycin (mTOR), which forms two distinct functional complexes :
mTORC1 that activates p70S6 kinase-1 to
enhance protein synthesis and
mTORC2 that activates Akt to promote cell survival ... Another molecular keystone involved in the hypertrophic growth process is the mammalian target of rapamycin (mTOR), which forms two distinct functional complexes : mTORC1 that activates p70S6 kinase-1 to enhance protein synthesis and
mTORC2 that
activates Akt to promote cell survival
Tamai et al., J Biol Chem 2013 (Hypertrophy) :
Thus,
Rheb dependent
mTORC1 activation becomes essential for cardiomyocyte hypertrophic growth after early postnatal period
Chiu et al., Amino Acids 2012 :
Thus,
glutamine stimulates
mTORC1 independent of cell leucine, suggesting the existence of two distinct stimulatory signals from either glutamine or EAA
Goncharova et al., Mol Cell Biol 2011 :
Our data demonstrate that
mTORC2 dependent activation of
RhoA is required for TSC2-null cell growth and survival and suggest that targeting both mTORC2 and mTORC1 by a combination of proapoptotic simvastatin and cytostatic rapamycin shows promise for combinational therapeutic intervention in diseases with TSC2 dysfunction
Huang et al., Cancer Lett 2009 (Carcinoma...) :
Also, we found blockage
mTORC1 inhibited
Cyclin D1 expression in CNE-2 cells and enhanced cell apoptosis
Palazuelos et al., J Biol Chem 2012 :
Likewise,
CB(2) receptor engagement induced cell proliferation in an
mTORC1 dependent manner both in embryonic cortical slices and in adult hippocampal NPs
Watterson et al., Neurosignals 2013 (Anorexia) :
Insulin and leptin increase mTORC1 activity in a phosphoinositide-3-kinase (PI3K)- and protein kinase B (PKB) dependent manner, compared to vehicle controls, whereas increasing
AMPK activity
inhibits mTORC1 activity and blocks the actions of the anorexigenic hormones ... Ghrelin mediates an
AMPK dependent decrease in
mTORC1 activity and increases hypothalamic AgRP mRNA levels, the latter effect being prevented by insulin in an mTORC1 dependent manner ... Ghrelin mediates an AMPK dependent decrease in
mTORC1 activity and increases hypothalamic AgRP mRNA levels, the latter effect being
prevented by
insulin in an mTORC1 dependent manner
Kenerson et al., Gastroenterology 2013 (Carcinoma, Hepatocellular...) :
In livers of albumin (Alb)-Cre mice, we selectively deleted
tuberous sclerosis (Tsc)1 , a negative
regulator of Ras homolog enriched in brain and
mTORC1 , along with Phosphatase and tensin homolog (Pten), a negative regulator of PI3K
O'Brien et al., Eur J Immunol 2011 :
The
TSC1/TSC2 complex has been shown to
inhibit mTORC1 signaling in cell line models ... Overall, our results demonstrate that
TSC1 differentially
regulates mTORC1 and mTORC2 activity, promotes T-cell survival, and is critical for normal mitochondrial homeostasis in T cells ... Overall, our results demonstrate that
TSC1 differentially
regulates mTORC1 and
mTORC2 activity, promotes T-cell survival, and is critical for normal mitochondrial homeostasis in T cells
Wong et al., Biochem Biophys Res Commun 2013 :
Thus, we found that inhibiting
mTORC1 dependent
4E-BP1 phosphorylation mimics the effect of hypoxia on TXNIP expression
Uhlenbrock et al., FEBS Lett 2009 :
Recent studies document that
Rheb activates
mTORC1 via direct, GTP dependent interaction with the peptidyl-prolyl-cis/trans-isomerase FKBP38, which is proposed to act as an inhibitor of mTORC1 ... Cell biological experiments illustrate that
FKBP38 plays only a very minor, if any, role in
mTORC1 activation
Yoshida et al., J Biol Chem 2011 :
Taken together, our results suggest that the
TSC complex
plays an important role in redox-sensitive
mTORC1 regulation and argues for the activation of mTORC1 in places other than the lysosome upon inhibition of the TSC complex
Meikle et al., J Neurosci 2008 (Disease Models, Animal...) :
Response of a neuronal model of tuberous sclerosis to
mammalian target of rapamycin (mTOR) inhibitors :
effects on
mTORC1 and Akt signaling lead to improved survival and function ... We have tested rapamycin and
RAD001 [ 40-O- ( 2-hydroxyethyl ) -rapamycin ], both mammalian target of rapamycin
mTORC1 inhibitors , as potential therapeutic agents in this model
Jin et al., Cancer Lett 2013 (Lung Neoplasms) :
Herein, we show that the constitutive overexpression of
Redd1 , a negative
regulator of
mTORC1 , induces Akt activation in lung cancer cells ... Therefore, the sustained overexpression of
Redd1 leads to
mTORC1 inhibition and to consequent Akt activation that is involved in cell survival
Shrivastava et al., Mol Cancer Ther 2011 (Breast Neoplasms) :
We showed that
CBD induces endoplasmic reticulum stress and, subsequently,
inhibits AKT and
mTOR signaling as shown by decreased levels of phosphorylated mTOR and 4EBP1, and cyclin D1
Jeon et al., Biochim Biophys Acta 2013 (Breast Neoplasms...) :
When SelW was down-regulated,
mTORC2 dependent phosphorylation of
Akt at Ser473 was decreased
Julien et al., Mol Cell Biol 2010 :
While mTOR complex 1 (mTORC1) regulates mRNA translation and ribosome biogenesis,
mTORC2 plays an important role in the phosphorylation and subsequent activation of
Akt ... Interestingly,
mTORC1 negatively
regulates Akt activation, but whether mTORC1 signaling directly targets mTORC2 remains unknown ... We found that
Rictor phosphorylation
requires mTORC1 activity and, more specifically, the p70 ribosomal S6 kinase 1 ( S6K1 ) ... However, cells expressing a Rictor T1135A mutant were found to have increased
mTORC2 dependent phosphorylation of
Akt ... In addition, phosphorylation of the Akt substrates FoxO1/3a and glycogen synthase kinase 3 alpha/beta ( GSK3 alpha/beta ) was found to be increased in these cells, indicating that S6K1 mediated phosphorylation of
Rictor inhibits
mTORC2 and Akt signaling
Roca et al., Neoplasia (New York, N.Y.) 2009 (Prostatic Neoplasms) :
D942, a pharmacological activator of AMPK, stunted
CCL2 induced
mTORC1 activity, survivin expression, and cell survival without significantly affecting Akt activity
Rhein et al., Ann Hematol 2011 (Leukemia, Experimental) :
However, Rapamycin did not completely inhibit
mTORC1 dependent phosphorylation of
4E-BP1
Lazorchak et al., Protein & cell 2011 (Cell Transformation, Neoplastic) :
We also propose a novel strategy to treat cancers based on our recent discovery that
mTORC2 regulates
Akt protein stability
Partovian et al., Mol Cell 2008 :
Reduced
mTORC2 activity in S4 ( -/- ) endothelial cells
results in decreased
FoxO1/3a and eNOS phosphorylation, decreased endothelial cell size, and increased arterial blood pressure in S4 ( -/- ) mice ... Reduced
mTORC2 activity in S4 ( -/- ) endothelial cells
results in decreased FoxO1/3a and
eNOS phosphorylation, decreased endothelial cell size, and increased arterial blood pressure in S4 ( -/- ) mice
Wenner , J Cell Physiol 2012 (Neoplasms) :
In addition, chemotherapeutic approaches based on
Akt activated
mTORC1 are described, and their relationship to the role of aerobic glycolysis in this protection
Gulhati et al., Carcinogenesis 2012 (Colorectal Neoplasms...) :
In this study, we show that inhibition of
mTORC1 with rapamycin
leads to feedback activation of
PI3K/Akt and Ras-MAPK signaling, resulting in cell survival and possible contribution to rapamycin resistance ... In this study, we show that inhibition of
mTORC1 with rapamycin
leads to feedback activation of PI3K/Akt and
Ras-MAPK signaling, resulting in cell survival and possible contribution to rapamycin resistance ... In this study, we show that inhibition of
mTORC1 with rapamycin
leads to feedback activation of
PI3K/Akt and Ras-MAPK signaling, resulting in cell survival and possible contribution to rapamycin resistance
Zhang et al., Breast Cancer Res Treat 2012 (Breast Neoplasms) :
Although NDGA stimulated AMP activated protein kinase (AMPK)/tuberous sclerosis complex 2 (TSC2) signaling, which negatively regulates mTORC1, AMPK and
TSC2 deletion could not
diminish the inhibition of
mTORC1 by NDGA ... Although NDGA stimulated AMP activated protein kinase (AMPK)/tuberous sclerosis complex 2 (TSC2) signaling, which negatively regulates mTORC1,
AMPK and TSC2 deletion could not
diminish the inhibition of
mTORC1 by NDGA ... Subsequent studies revealed that NDGA may also direct target mTORC1 complex because NDGA suppressed amino acids- and
insulin stimulated
mTORC1 and acted like rapamycin to disrupt mTOR-Raptor interaction ... Disruption of
mTOR-Raptor complex and
activation of
AMPK/TSC signaling may contribute to inhibitory effects of NDGA against mTORC1 ... Disruption of
mTOR-Raptor complex and
activation of
AMPK/TSC signaling may contribute to inhibitory effects of NDGA against mTORC1
Deshmukh et al., Mol Endocrinol 2008 :
However, in WT mice, preincubation with AICAR completely inhibited insulin induced phosphorylation of mTOR targets, suggesting
mTOR signaling is
blocked by prior
AMPK activation
Jones et al., PLoS Biol 2009 :
These findings identify new physiological roles for
TORC2 ,
mediated by
SGK , in regulation of C. elegans lipid accumulation and growth, and they challenge the notion that AKT is the primary effector of TORC2 function
Hall et al., Breast Cancer Res Treat 2012 (Breast Neoplasms) :
Previous studies have alternatively suggested that either
mTORC1 or mTORC2 is exclusively
required for
SGK1 's Ser422 phosphorylation and activation in breast cancer cells ... Previous studies have alternatively suggested that either mTORC1 or
mTORC2 is exclusively
required for
SGK1 's Ser422 phosphorylation and activation in breast cancer cells
Rodrik-Outmezguine et al., Cancer Discov 2011 :
mTOR kinase inhibitors
block mTORC1 and
mTORC2 and thus do not cause the mTORC2 activation of AKT observed with rapamycin ... mTOR kinase inhibitors block mTORC1 and mTORC2 and thus do not cause the
mTORC2 activation of
AKT observed with rapamycin ...
mTOR kinase inhibitors
block mTORC1 and mTORC2 and thus do not cause the mTORC2 activation of AKT observed with rapamycin ... Inhibition of
mTORC2 leads to AKT serine 473 ( S473 ) dephosphorylation and a rapid but transient inhibition of AKT T308 phosphorylation and
AKT signaling
Liu et al., J Neuroendocrinol 2011 :
The demonstration that TORC2 translocates to the nucleus of hypothalamic CRH neurones and interacts with the CRH promoter in conjunction with the activation of CRH transcription during restraint stress, provides strong evidence for the
involvement of
TORC2 in the physiological regulation of
CRH transcription
Guo et al., Mol Cancer Res 2013 :
Loss of either
TSC1 or TSC2 in TSC hamartomas
leads to activation of
mTORC1 ... Loss of either TSC1 or
TSC2 in TSC hamartomas
leads to activation of
mTORC1
Wang et al., J Mol Cell Cardiol 2008 (Cardiomegaly) :
Ras homolog enriched in brain (Rheb) positively
regulates mTORC1 ... Overexpression of
Rheb in ARVC
activated mTORC1 signaling, several components of the translational machinery and stimulated protein synthesis
Horak et al., Proc Natl Acad Sci U S A 2010 (Cell Transformation, Viral...) :
Surprisingly, however,
HIF-1 up-regulation in REDD1 ( -/- ) cells is largely
independent of
mTORC1 activity
Fujishita et al., Cell cycle (Georgetown, Tex.) 2009 (Adenoma...) :
We have recently found that the mTORC1 pathway is activated in intestinal adenomas of Apc mutant mice, accompanied by an elevated level of mTOR protein, and that treatment with
RAD001 , an
mTORC1 inhibitor , suppresses the growth of these polyps
Wong et al., Curr Opin Pharmacol 2010 (Metabolic Diseases) :
SREBP-1c can be
induced by
mTORC1 , bifurcating lipogenesis from AKT activated gluconeogenesis
Martina et al., J Cell Biol 2013 :
Interaction of TFEB with active Rag heterodimers promoted recruitment of TFEB to lysosomes, leading to
mTORC1 dependent phosphorylation and inhibition of
TFEB
Pearce et al., Biochem J 2011 :
Both complexes phosphorylate the hydrophobic motifs of AGC kinase family members : mTORC1 phosphorylates S6K ( S6 kinase ), whereas
mTORC2 regulates phosphorylation of Akt, PKCa ( protein kinase Ca ) and
SGK1 ( serum- and glucocorticoid induced protein kinase 1 ) ... Both complexes phosphorylate the hydrophobic motifs of AGC kinase family members : mTORC1 phosphorylates S6K ( S6 kinase ), whereas
mTORC2 regulates phosphorylation of
Akt , PKCa ( protein kinase Ca ) and SGK1 ( serum- and glucocorticoid induced protein kinase 1 ) ... Taken together, these results suggest that Protor-1 may play a role in enabling
mTORC2 to efficiently
activate SGK1 , at least in the kidney
Fournier et al., Mol Cell Biol 2013 :
mTORC1 specifically drives the eIF4E mediated formation of SG through the phosphorylation of 4E-BP1, a key factor known to inhibit formation of the
mTORC1 dependent
eIF4E-eIF4GI interactions
Wahdan-Alaswad et al., Mol Cancer Res 2012 (Prostatic Neoplasms) :
Intriguingly, silencing raptor alone enhanced, whereas silencing rictor repressed, the phosphorylation of Smad1/5, indicating that mTORC1 represses, whereas
mTORC2 activates ,
BMP signaling
Li et al., J Biol Chem 2013 :
In Drosophila S2 cells and mammalian cells, knockdown of MARK family member increased mTORC1 activity, whereas overexpression of
MARK4 in mammalian cells significantly
inhibited mTORC1 activity ... Interestingly, MARK4 selectively inhibits
mTORC1 activation by Rag GTPases, which are involved in amino acid signaling, but does not
inhibit the effect of
Rheb , which directly binds to and activates mTORC1 ... Interestingly,
MARK4 selectively
inhibits mTORC1 activation by Rag GTPases, which are involved in amino acid signaling, but does not inhibit the effect of Rheb, which directly binds to and activates mTORC1 ... Interestingly,
MARK4 selectively
inhibits mTORC1 activation by Rag GTPases, which are involved in amino acid signaling, but does not inhibit the effect of Rheb, which directly binds to and activates mTORC1
Breuleux et al., Mol Cancer Ther 2009 (Neoplasms) :
RAD001 ( everolimus ), an
mTORC1 ( mTOR/raptor )
inhibitor , has broad antitumor activity in preclinical models and cancer patients ... Strikingly, rictor down-regulation attenuated
AKT S473 phosphorylation
induced by
mTORC1 inhibition
Settembre et al., EMBO J 2012 :
Conversely, pharmacological inhibition of
mTORC1 , as well as starvation and lysosomal disruption,
activates TFEB by promoting its nuclear translocation ... Interestingly, the
Rag GTPase complex, which senses lysosomal amino acids and
activates mTORC1 , is both necessary and sufficient to regulate starvation- and stress induced nuclear translocation of TFEB
Brito et al., Atherosclerosis 2009 (Atherosclerosis) :
The activation of
mTOR signaling by oxLDL,
requires the upstream activation of PI3K and
Akt , as assessed by the inhibitory effect of the PI3K inhibitor Ly294002 on mTOR activation and DNA synthesis ... The activation of
mTOR signaling by oxLDL,
requires the upstream activation of
PI3K and Akt, as assessed by the inhibitory effect of the PI3K inhibitor Ly294002 on mTOR activation and DNA synthesis
Xu et al., J Biol Chem 2011 :
Amino acid- and glucose induced PLD and
mTORC1 activity were also
dependent on the GTPases RalA and
ARF6 and the type III phosphatidylinositol-3-kinase hVps34 ... Amino acid- and glucose induced PLD and
mTORC1 activity were also
dependent on the GTPases RalA and ARF6 and the type III phosphatidylinositol-3-kinase
hVps34 ... Amino acid- and glucose induced PLD and
mTORC1 activity were also
dependent on the GTPases
RalA and ARF6 and the type III phosphatidylinositol-3-kinase hVps34
Mansley et al., Br J Pharmacol 2010 :
TORC2 , but not TORC1, is also
involved in glucocorticoid induced
SGK1 activation but its role is permissive
Huang et al., Biochem Soc Trans 2009 :
Through negative-feedback mechanisms,
mTORC1 activity
inhibits growth factor stimulation of
PI3K
Wang et al., Cancer Res 2008 (Lung Neoplasms) :
The present work focused on addressing the
role of
mTOR/rictor in
mTOR inhibitor induced Akt activation and the effect of sustained Akt activation on mTOR targeted cancer therapy ... Collectively, we conclude that inhibition of the
mTOR/raptor complex initiates
Akt activation independent of mTOR/rictor
Jung et al., Autophagy 2011 :
ULK1 inhibits the kinase activity of
mTORC1 and cell proliferation ... ( 1-3 ) Here, we investigated how ULK1 regulates mTORC1 signaling, and found that
ULK1 inhibits the kinase activity of
mTORC1 and cell proliferation ... Deficiency or knockdown of ULK1 or its homolog ULK2
enhanced mTORC1 signaling, cell proliferation rates and accumulation of cell mass, whereas overexpression of
ULK1 had the opposite effect ... The stimulatory effect of ULK1 knockdown on mTORC1 signaling occurred even in the absence of
tuberous sclerosis complex 2 (TSC2) , the negative
regulator of
mTORC1 signaling ... In addition,
ULK1 was found to bind raptor, induce its phosphorylation, and
inhibit the kinase activity of
mTORC1 ... In addition, ULK1 was found to bind
raptor , induce its phosphorylation, and
inhibit the kinase activity of
mTORC1 ... In addition,
ULK1 was found to bind raptor, induce its phosphorylation, and
inhibit the kinase activity of
mTORC1 ... These results demonstrate that
ULK1 negatively
regulates the kinase activity of
mTORC1 and cell proliferation in a manner independent of Atg5 and TSC2
Chong et al., Oxidative medicine and cellular longevity 2010 (Neurodegenerative Diseases) :
The function of
mTOR signaling is
mediated primarily through two mTOR complexes :
mTORC1 and mTORC2 ... The function of
mTOR signaling is
mediated primarily through two mTOR complexes : mTORC1 and
mTORC2
Xie et al., Cell Signal 2011 :
In this study, we show that the pharmacological elevation of [ cAMP ] ( i ) in mouse embryonic fibroblasts ( MEFs ) and human embryonic kidney 293 (HEK293) cells inhibits
mTORC1 activation via a
PKA dependent mechanism ... We provide evidence that this cAMP dependent inhibition of
mTORC1/2 is
caused by the dissociation of mTORC1 and 2 and a reduction in
mTOR catalytic activity, as determined by its auto-phosphorylation on Ser2481
Høyer-Hansen et al., Autophagy 2007 (Calcium Signaling) :
The present study suggests hat
AMPK inhibits
mTORC1 and autophagy also in nonstarved cells
Salles et al., J Neurochem 2013 :
Transient and rapid
activation of Akt/GSK-3ß and
mTORC1 signaling by
D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens
Fujishita et al., Proc Natl Acad Sci U S A 2008 (Adenoma...) :
These results suggest that the
Wnt signaling
contributes to
mTORC1 activation through the increased level of mTOR and that the activation plays important roles in the intestinal polyp formation and growth
Prizant et al., J Cell Biochem 2008 :
This confirms specific
mTORC1 regulation of
S6K1 phosphorylation
Li et al., Am J Physiol Cell Physiol 2011 (MAP Kinase Signaling System) :
mTORC1 inhibition
increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON ... Here, we demonstrate that the inhibition of mTORC1 by rapamycin (
mTORC1 inhibitor ), torin1 ( both mTORC1 and mTORC2 inhibitor ) or short hairpin RNA mediated knockdown of mTOR, regulatory associated protein of mTOR ( RAPTOR ), and
p70 S6 kinase (p70S6K) increased basal NT release via upregulating NT gene expression in BON cells
Yan et al., J Cell Biochem 2010 :
VEGF stimulation
results in
mTOR signaling activation which changes the phosphorylation status of 4E-BP1, the downstream of mTOR signaling, and ultimately contributes to the translation initiation of Livin protein
Burgos et al., Domest Anim Endocrinol 2010 :
In addition,
IGF-1 stimulated
mTORC1 kinase activity toward 4E-BP1 in vitro
Knizhnik et al., J Cell Biochem 2012 (MAP Kinase Signaling System...) :
Namely, we showed that
Arf6 in a
PLD-mTORC1 dependent manner activates S6K1 kinase, a well-known regulator of mitogen stimulated translation initiation
Huang et al., Cancer Res 2009 (Angiomyolipoma...) :
We also show that the
TSC1-TSC2 complex can directly
stimulate the in vitro kinase activity of
mTORC2
Canettieri et al., Cell Metab 2005 :
Dual
role of the coactivator
TORC2 in modulating hepatic glucose output and
insulin signaling ... Here, we show that, in parallel with their effects on glucose output, CREB and
TORC2 also
enhance insulin signaling in liver by stimulating expression of the insulin receptor substrate 2 (IRS2) gene
Peterson et al., Cell 2009 (Multiple Myeloma) :
Loss of
DEPTOR activates S6K1, Akt, and SGK1, promotes cell growth and survival, and
activates mTORC1 and mTORC2 kinase activities ... Loss of
DEPTOR activates S6K1, Akt, and SGK1, promotes cell growth and survival, and
activates mTORC1 and
mTORC2 kinase activities
Schwarz et al., Circ Res 2009 (Disease Models, Animal...) :
These results strongly indicate that
CXCR3 dependent activation of
mTORC1 directly links stimulation of the Th1 immune system with the proliferative response of intimal cells in vascular remodeling
Parrales et al., Cell Signal 2013 :
ERK1/2 dependent activation of
mTOR/mTORC1/p70S6K regulates thrombin induced RPE cell proliferation ... Since
Akt functions as an upstream activator of mechanistic target of rapamycin complex 1 ( mTORC1 ) and is also a downstream
target for
mTORC2 , the aim of this work was to determine whether mTOR is involved in thrombin induced RPE cell proliferation by regulating cyclin D1 expression in immortalized rat RPE-J cell line
Kaur et al., Proc Natl Acad Sci U S A 2012 :
We provide evidence that
mTORC2 complexes
control IFN induced phosphorylation of
AKT on serine 473 and their function is ultimately required for IFN dependent gene transcription via interferon stimulated response elements
Najafov et al., Biochem J 2012 (Neoplasms) :
Akt is
activated by phosphorylation of its T-loop residue ( Thr ( 308 ) ) by PDK1 ( 3-phosphoinositide dependent kinase-1 ) and its C-terminal hydrophobic motif ( Ser ( 473 ) ) by
mTORC2 [ mTOR ( mammalian target of rapamycin ) complex 2 ] ... Akt is
activated by phosphorylation of its T-loop residue ( Thr ( 308 ) ) by PDK1 ( 3-phosphoinositide dependent kinase-1 ) and its C-terminal hydrophobic motif ( Ser ( 473 ) ) by
mTORC2 [
mTOR ( mammalian target of rapamycin ) complex 2 ]
Toschi et al., J Biol Chem 2008 :
These data indicate that although HIF1 alpha is dependent on both mTORC1 and mTORC2,
HIF2 alpha is
dependent only on
mTORC2 ... These data indicate that although
HIF1 alpha is
dependent on both mTORC1 and
mTORC2 , HIF2 alpha is dependent only on mTORC2 ... These data indicate that although
HIF1 alpha is
dependent on both
mTORC1 and mTORC2, HIF2 alpha is dependent only on mTORC2
Timmerman et al., J Clin Endocrinol Metab 2010 :
During insulin infusion, blood flow and capillary recruitment increased in the control ( P < 0.05 ) group only ;
Akt phosphorylation and glucose uptake
increased in both groups ( P < 0.05 ), with no group differences ; and
mTORC1 signaling increased more in control ( P < 0.05 ) than in L-NMMA
Xu et al., Dev Dyn 2009 :
It is proposed that
mTORC1 may be
involved in the control of MPF by regulating
S6K1 during the early development of mouse embryos
Shanmugasundaram et al., Oncogene 2013 (Carcinoma, Renal Cell...) :
Here we provide additional genetic evidence that
PI3K signaling
activates mTORC2 kinase activity ... We also demonstrate a novel
role for
mTORC2 in the modulation of nuclear
p27 levels
Michels et al., Mol Cell Biol 2010 :
mTORC1 directly phosphorylates and
regulates human
MAF1 ... Our results describe molecular mechanisms by which
mTORC1 controls human
MAF1 , a key repressor of RNA polymerase III transcription, and add a new branch to the signal transduction cascade immediately downstream of TORC1
Lisse et al., FASEB J 2011 (Bone Neoplasms...) :
DDIT4 , an
inhibitor of
mTOR signaling , is a direct target for 1,25 ( OH ) ( 2 ) D ( 3 ) and VDRE-BP, and functions to suppress cell proliferation in response to vitamin D
Liu et al., J Biol Chem 2012 (Diabetes Mellitus, Type 2...) :
Brown adipose tissue insulin sensitivity and reduced adiposity of LRP6 ( +/- ) mice were accounted for by diminished
Wnt dependent
mTORC1 activity and enhanced expression of brown adipose tissue PGC1-a and UCP1
Sarbassov et al., Mol Cell 2006 :
mTORC2 phosphorylates and
activates Akt/PKB , a key regulator of cell survival ...
mTORC2 phosphorylates and
activates Akt/PKB , a key regulator of cell survival
Palaniappan et al., Mol Endocrinol 2012 :
Furthermore, the pharmacological inhibition of
mTORC1 or ribosomal protein S6 kinase 1 signaling
prevented the LH/hCG induced phosphorylation of
CREB
Cybulski et al., Proc Natl Acad Sci U S A 2009 (Fatty Liver) :
mTORC2 , which consists of rictor, mSIN1, mLST8, and mTOR, is
activated by
insulin/IGF1 and phosphorylates Ser-473 in the hydrophobic motif of Akt/PKB ...
mTORC2 , which consists of rictor, mSIN1, mLST8, and mTOR, is
activated by
insulin/IGF1 and phosphorylates Ser-473 in the hydrophobic motif of Akt/PKB
Melnik , World journal of diabetes 2012 :
High consumption of leucine-rich proteins explains exaggerated
mTORC1 dependent
insulin secretion, increased ß-cell growth and ß-cell proliferation promoting an early onset of replicative ß-cell senescence with subsequent ß-cell apoptosis
Wang et al., J Immunol 2011 (Inflammation) :
At the transcriptional level,
mTORC1 inhibition
reduced the DNA binding of
CREB and this effect was reversed by GSK3 inhibition ... As a result,
mTORC1 inhibition
increased the levels of NF-?B
p65 associated with CREB binding protein ... As a result,
mTORC1 inhibition
increased the levels of
NF-?B p65 associated with CREB binding protein
Chen et al., J Invest Dermatol 2013 (Psoriasis) :
mTORC2-PKBa/Akt1 Serine 473 Phosphorylation Axis Is
Essential for Regulation of
FOXP3 Stability by Chemokine CCL3 in Psoriasis
Chuluunbaatar et al., Genes Dev 2010 (Herpes Simplex) :
Viruses producing methyl-7 ( m7 ) GTP capped mRNAs, like Herpes Simplex Virus-1 ( HSV-1 ), stimulate cap dependent translation by activating
mTORC1 to
inhibit the translational repressor
4E-binding protein 1 (4E-BP1)
Liu et al., Oncogene 2008 :
Both
S6K1 and 4E-BP1 pathways,
mediated by the
mTOR-raptor complex , are involved in the regulation of IGF-I stimulated F-actin reorganization, but only the former controls IGF-I stimulated phosphorylation of the focal adhesion proteins
Moschella et al., Cell Signal 2013 :
Since mTORC2 is known to mediate the activation of a prosurvival kinase, Akt, we analyzed whether
mTORC2 directly
mediates Akt activation or whether it requires the participation of another prosurvival kinase, PKCe ( epsilon isoform of protein kinase-C )
DeYoung et al., Genes Dev 2008 (Breast Neoplasms) :
Endogenous
REDD1 is
required for both dissociation of endogenous TSC2/14-3-3 and inhibition of
mTORC1 in response to hypoxia ... REDD1 mutants that fail to bind 14-3-3 are defective in eliciting
TSC2/14-3-3 dissociation and
mTORC1 inhibition , while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1 ... REDD1 mutants that fail to bind 14-3-3 are defective in eliciting
TSC2/14-3-3 dissociation and
mTORC1 inhibition , while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1
Liu et al., Endocrinology 2012 :
Overexpression of either SIK1 or
SIK2 in 4B cells
reduced nuclear
TORC2 levels ( Western blot ) and inhibited forskolin stimulated CRH transcription ( luciferase assay )
Peña-Llopis et al., EMBO J 2011 (MAP Kinase Signaling System) :
Regulation of
TFEB and V-ATPases by
mTORC1 ...
mTORC1 regulates
V-ATPase expression both in cells and in mice ...
V-ATPase regulation by
mTORC1 involves a transcription factor translocated in renal cancer, TFEB ...
mTORC1 coordinately
regulates TFEB phosphorylation and nuclear localization and in a manner dependent on both TFEB and V-ATPases, mTORC1 promotes endocytosis
Pracheil et al., Genetics 2012 :
More importantly, characterization of lst8d bypass mutants reveals a
role for protein
phosphatase 2A (PP2A) in the regulation of
TORC2 signaling
Zhang et al., PloS one 2009 :
Loss of function of the TSC1-TSC2 complex results in constitutive mTORC1 signaling and, through
mTORC1 dependent feedback mechanisms and loss of
mTORC2 activity, leads to a concomitant block of Akt signaling to its other downstream targets ... Loss of function of the
TSC1-TSC2 complex results in constitutive
mTORC1 signaling and, through mTORC1 dependent feedback mechanisms and loss of mTORC2 activity, leads to a concomitant block of Akt signaling to its other downstream targets ... In examining the requirements for different Akt mediated phosphorylation sites on TSC2, we find that only
TSC2 mutants lacking all five previously identified Akt sites fully
block insulin stimulated
mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis ... In examining the requirements for different Akt mediated phosphorylation sites on TSC2, we find that only TSC2 mutants lacking all five previously identified Akt sites fully block
insulin stimulated
mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis
Kim et al., Mol Cell 2013 (Breast Neoplasms...) :
The
TTT-RUVBL complex was
necessary for the interaction between
mTORC1 and Rag and formation of mTORC1 obligate dimers
Dey et al., PloS one 2012 (Hypertrophy) :
Tuberin and PRAS40, two other Akt substrates, and endogenous
inhibitors of
mTORC1 , regulate mesangial cell hypertrophy
Hietakangas et al., BMC cancer 2008 (Breast Neoplasms...) :
TOR complex 2 (TORC2) activates
AKT by phosphorylating it on the ` hydrophobic motif ' site
Kelleher et al., Am J Physiol Endocrinol Metab 2013 :
In conclusion, the results show an immobilization induced attenuation of
mTORC1 signaling
mediated by induction of
REDD1/2 and defective p70S6K1 phosphorylation
Sancak et al., Cell 2010 (MAP Kinase Signaling System) :
Thus,
Rag-Ragulator mediated translocation of
mTORC1 to lysosomal membranes is the key event in amino acid signaling to mTORC1
Salmond et al., J Allergy Clin Immunol 2012 (Pneumonia) :
Our goal was to investigate a role for mammalian target of rapamycin
(mTOR) signaling in the activation of T ( H ) 2 and ILC responses and the
induction of airway inflammation by
IL-33
Hong-Brown et al., Am J Physiol Cell Physiol 2012 :
Rag GTPases and
AMPK/TSC2/Rheb mediate the differential regulation of
mTORC1 signaling in response to alcohol and leucine ... Rag GTPases and
AMPK/TSC2/Rheb mediate the differential regulation of
mTORC1 signaling in response to alcohol and leucine ... Rag GTPases and
AMPK/TSC2/Rheb mediate the differential regulation of
mTORC1 signaling in response to alcohol and leucine ... Overexpression of constitutively active ( ca )
RagA and caRagC
increased mTORC1 activity, as determined by increased S6K1 phosphorylation
Suryawan et al., J Appl Physiol 2010 :
The present study aimed to characterize in more detail the
effects of the postprandial rise in
INS and AA on the activation and abundance of
mTORC1 regulators in muscle and how this is modified by development ... Our results suggest that the enhanced activation of
mTORC1 in muscle of neonatal pigs is in part
due to regulation by PRAS40,
PLD1 , and the Rag GTPases ... Our results suggest that the enhanced activation of
mTORC1 in muscle of neonatal pigs is in part
due to regulation by PRAS40,
PLD1 , and the Rag GTPases
Völkers et al., Proc Natl Acad Sci U S A 2013 (Cardiomegaly) :
Mechanistic target of rapamycin complex 1 ( mTORC1 ), necessary for cellular growth, is
regulated by intracellular signaling mediating inhibition of
mTORC1 activation ... Inhibition of
mTORC1 by PRAS40 preferentially
promotes protective
mTORC2 signaling in chronic diseased myocardium
Chong et al., Prog Neurobiol 2012 (Neurodegenerative Diseases) :
mTOR signaling is
dependent upon the mTORC1 and
mTORC2 complexes that are composed of mTOR and several regulatory proteins including the tuberous sclerosis complex ( TSC1, hamartin/TSC2, tuberin )
Nascimento et al., Arch Physiol Biochem 2009 (Diabetes Mellitus, Type 2...) :
The interaction of PRAS40 with the
mTOR complex 1 (mTORC1) inhibits the activity of
mTORC1
Liao et al., J Cell Sci 2010 :
Chemotactic activation of Dictyostelium AGC-family kinases
AKT and PKBR1
requires separate but coordinated functions of PDK1 and
TORC2
Boulbés et al., Biochem Biophys Res Commun 2011 :
Based on our study we suggest that the
mTORC2 dependent phosphorylation of
Akt on Ser-473 takes place on the surface of ER
Beharry et al., Proc Natl Acad Sci U S A 2011 :
Here, we find that a novel
Pim kinase inhibitor, SMI-4a, or Pim-1 siRNA blocked the rapamycin-sensitive mammalian target of rapamycin ( mTORC1 ) activity by stimulating the phosphorylation and thus
activating the
mTORC1 negative regulator AMP dependent protein kinase (AMPK)
Villanueva et al., Endocrinology 2009 :
Leptin and feeding
regulate the mammalian target of rapamycin complex 1 ( mTORC1 ) in the hypothalamus, and hypothalamic
mTORC1 contributes to the control of feeding and energy balance ... To determine the mechanisms by which leptin modulates mTORC1 in specific hypothalamic neurons, we immunohistochemically assessed the
mTORC1 dependent phosphorylation of
ribosomal protein S6 (pS6) ... In contrast, fasting and
leptin deficiency
suppress VMH
mTORC1 signaling ... Furthermore, ghrelin, which activates orexigenic ARC neurons, increased ARC
mTORC1 activity and
induced colocalized pS6- and
c-Fos-IR
Ikenoue et al., Methods Enzymol 2009 :
In turn,
mTORC1 regulates the activity of the translational machinery by modulating S6 kinase ( S6K ) activity and
eIF4E binding protein 1 ( 4E-BP1 ) through direct phosphorylation
Burgos et al., Horm Metab Res 2013 :
The inhibitory
effects of
AMPK activation on
mTORC1 signaling were associated with a marked increase in Ser792 phosphorylation on raptor